287 KiB
287 KiB
1 | measure_id | measure_name | location_id | location_name | sex_id | sex_name | age_id | age_name | cause_id | cause_name | metric_id | metric_name | year | val | upper | lower |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2005 | 1.0038642556239408 | 1.2106491028071278 | 0.8415599316737252 |
3 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2005 | 0.7990979741754611 | 1.1200366386018297 | 0.5710009004722565 |
4 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2005 | 0.3972951841135383 | 0.5683933768565332 | 0.274485449698992 |
5 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2005 | 4.9036552783529865 | 9.719969741118879 | 2.073055238589131 |
6 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2005 | 4.726530255252192 | 6.038103643552345 | 3.6448950104316666 |
7 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2005 | 60.864346775952214 | 73.06888493010332 | 50.204240011194734 |
8 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2005 | 807.2584639401139 | 1703.459168360532 | 382.27565681274274 |
9 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2005 | 127.94892301025351 | 137.21855118213824 | 115.27948517976293 |
10 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2005 | 117.46163137542945 | 184.22750914465252 | 69.1973236583267 |
11 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2005 | 63.458313883430094 | 71.90137327612352 | 55.02704122743823 |
12 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2005 | 627.0392971394512 | 1364.946564616699 | 102.87987638661613 |
13 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2005 | 91.09132141216006 | 120.81171511654709 | 66.40732216386655 |
14 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2005 | 6.651759924414563 | 8.987844512114423 | 4.670176075687349 |
15 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2007 | 0.0 | 0.0 | 0.0 |
16 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2007 | 7.6193336529790265 | 8.16070959970186 | 7.127860369226223 |
17 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2007 | 213.98154365251193 | 235.16939176745777 | 196.54241347560665 |
18 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2007 | 115.14517086046938 | 117.90026400150381 | 110.46250658093588 |
19 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2007 | 1174.2275426333579 | 1226.982536249016 | 1100.9145142615848 |
20 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2007 | 343.01666258964354 | 484.1252154013582 | 236.49748509195177 |
21 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2007 | 504.085376623889 | 513.7045350310435 | 491.05705878014066 |
22 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2007 | 134.8098304766409 | 139.35876475829656 | 126.84305486957992 |
23 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2007 | 164.262762503588 | 167.2233038962699 | 159.38113284348984 |
24 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2007 | 1316.467934621123 | 1356.2612480004755 | 1248.2018687909863 |
25 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2007 | 453.62954232486993 | 479.8369445262573 | 426.45192678044083 |
26 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2007 | 68.861249679354 | 71.04418417707345 | 66.11220980436138 |
27 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2007 | 59.62438645160671 | 63.57653318047036 | 54.99612914155506 |
28 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2007 | 242.34827650213668 | 261.3206281344903 | 223.9338095532434 |
29 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2007 | 505.5855756975575 | 527.5413929218544 | 474.40930863012557 |
30 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2007 | 289.69628546055486 | 298.19899943729615 | 273.9416965015433 |
31 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2007 | 96.44692703117829 | 101.789071377978 | 91.32558030833474 |
32 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2007 | 38.10331956406408 | 45.701882019467035 | 32.01045269852879 |
33 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2007 | 261.2271652869309 | 329.89615440466673 | 194.82509053917514 |
34 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2007 | 61.90314219207348 | 78.85641128785744 | 47.45630022224499 |
35 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2007 | 381.38579852371663 | 766.6002620593098 | 185.27921080722984 |
36 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2007 | 1.0557794618328606 | 1.540260210477463 | 0.701370935254106 |
37 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2007 | 18.046419636326426 | 19.566634361302338 | 16.494253862853586 |
38 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2006 | 0.0 | 0.0 | 0.0 |
39 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2006 | 8.203993387154114 | 8.772930200392585 | 7.679408865193807 |
40 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2006 | 230.00494075119613 | 251.01233173620858 | 213.04428761730892 |
41 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2006 | 111.77408235103859 | 114.48416285040378 | 107.464811446231 |
42 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2007 | 365.18734681062006 | 455.6787980954919 | 287.5963556841561 |
43 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2007 | 833.0487207540345 | 940.7622810259381 | 721.1992452503173 |
44 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2007 | 878.9098267858491 | 1190.4285789791381 | 622.990438505336 |
45 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2007 | 139.3416346694814 | 198.51392384318186 | 92.05623837309291 |
46 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2007 | 744.450039101626 | 1003.5209228010294 | 509.57340376981216 |
47 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2007 | 27.06709606981544 | 42.478443718637294 | 16.32571901274773 |
48 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2007 | 72.7912127090556 | 120.57634697502446 | 40.59347216337225 |
49 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2007 | 196.27798431539918 | 274.2618251463419 | 136.7149947571919 |
50 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2007 | 21.195499897854514 | 35.005285115631516 | 11.428254083062377 |
51 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2007 | 17.659836721620202 | 18.389391974565154 | 16.970803437196555 |
52 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2007 | 196.5383210888812 | 204.17384845288765 | 184.9180437358283 |
53 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2007 | 94.44035347343987 | 97.5997749689859 | 89.1989746572362 |
54 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2007 | 212.61498684162208 | 218.700363664433 | 202.14845798425807 |
55 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2007 | 1103.4414021253242 | 1189.7424171376072 | 1006.7031237743306 |
56 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2007 | 1139.522527916562 | 1360.270584997194 | 951.7073619865108 |
57 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2006 | 1160.850863654109 | 1212.103125216741 | 1089.2553141384844 |
58 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2006 | 328.95285095771686 | 465.5556269272 | 227.77986464482683 |
59 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2006 | 495.4225336828935 | 504.6623737045451 | 482.85791388497523 |
60 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2006 | 137.83025089561306 | 142.21782575148458 | 130.00164794800403 |
61 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2006 | 164.1911374616873 | 167.04083113993485 | 159.51549021445413 |
62 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2006 | 1335.9051854089892 | 1375.89810630582 | 1266.9836097021187 |
63 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2006 | 462.8278694952113 | 489.4715531700733 | 435.6363653074047 |
64 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2006 | 68.86108677960888 | 71.0174005399701 | 66.24755076415215 |
65 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2006 | 58.956417188194344 | 62.644579161765684 | 54.56401874211461 |
66 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2006 | 242.60589257566966 | 261.1741731733906 | 224.79982733958778 |
67 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2006 | 507.65089448016516 | 529.7710672895407 | 475.9810313101167 |
68 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2006 | 286.4008658782048 | 294.61444882173765 | 271.17394750997306 |
69 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2006 | 97.28104178973835 | 102.67265343136812 | 92.26705092971811 |
70 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2006 | 37.262073499130466 | 44.557618426274324 | 31.29934618165788 |
71 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2006 | 260.26683091358376 | 328.84351744075747 | 193.71833883529908 |
72 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2007 | 547.4085036420747 | 594.829571785147 | 489.0141517429079 |
73 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2007 | 599.8494224983946 | 823.6285985150122 | 420.3798230850212 |
74 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2006 | 61.45969455584678 | 77.95077371336626 | 47.07928044831681 |
75 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2006 | 368.81779000264646 | 742.0290246251775 | 178.80204254799125 |
76 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2006 | 1.101293775967933 | 1.5986390900797496 | 0.7289856979086939 |
77 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2006 | 18.333573039228128 | 19.874964468902608 | 16.754132749446942 |
78 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2006 | 18.462998755987424 | 19.237266285260038 | 17.777456787192 |
79 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2006 | 200.27118787692777 | 207.93002636474077 | 188.92336608475165 |
80 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2006 | 94.9394146434624 | 97.95905179624869 | 89.7664528422289 |
81 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2006 | 215.27016842385086 | 221.30725546889198 | 205.0500651497189 |
82 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2006 | 1124.0834793120794 | 1210.0468927198908 | 1026.875969186263 |
83 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2006 | 1135.6781636593723 | 1350.749883961468 | 952.624039499875 |
84 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2005 | 0.0 | 0.0 | 0.0 |
85 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2007 | 0.43474741342518586 | 0.4718064815654348 | 0.3815011130506725 |
86 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2007 | 10.601893134603857 | 11.060748709468735 | 10.191929713343521 |
87 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2006 | 367.10616729489067 | 458.5419677426456 | 289.51967082125583 |
88 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2006 | 799.7781030812667 | 905.524426719223 | 691.112912860199 |
89 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2006 | 877.9278403559716 | 1188.3803027561805 | 620.5373096923664 |
90 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2006 | 139.20957398298597 | 198.89880026965218 | 92.18676015797718 |
91 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2006 | 752.7574941827877 | 1013.5656899770306 | 515.4100578123013 |
92 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2006 | 27.187409303591828 | 42.33695229079959 | 16.66274019765584 |
93 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2006 | 73.1269444769678 | 121.0318682892906 | 41.02034681334689 |
94 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2006 | 196.60038952477387 | 275.3998019967359 | 136.27472211679273 |
95 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2006 | 21.32780777124681 | 35.31650606742378 | 11.449768321544543 |
96 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2007 | 164.6560288685762 | 253.5288420439887 | 104.13468544686947 |
97 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2005 | 138.32623028627145 | 142.73772982386197 | 130.47487737511236 |
98 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2005 | 166.1086855402882 | 168.8950265698763 | 161.41464492814367 |
99 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2006 | 538.7523849830599 | 586.7184067095269 | 482.4144054962691 |
100 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2005 | 1166.4509375339205 | 1217.5296692072034 | 1097.6101931283374 |
101 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2005 | 322.6711219935185 | 457.0708480102893 | 224.3930549185982 |
102 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2005 | 490.97487466962093 | 500.27108518299957 | 479.05490952865 |
103 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2006 | 602.5088639066397 | 827.1141944717244 | 421.8924622420935 |
104 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2005 | 18.378953920979495 | 19.15163629680091 | 17.68867292614756 |
105 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2005 | 204.57338704396787 | 212.61303552251215 | 193.2474965595285 |
106 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2005 | 95.38006699697776 | 98.41782554498033 | 90.2908272211936 |
107 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2005 | 215.23344410020627 | 220.9300832737019 | 205.11793696763473 |
108 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2005 | 1147.0724217688378 | 1233.8216981388316 | 1049.4567764934397 |
109 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2005 | 1127.4998926711246 | 1337.742057643321 | 950.2365942998036 |
110 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2005 | 60.90770063678833 | 77.16770439934473 | 46.88098180649939 |
111 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2005 | 359.8237312702335 | 725.6888214168198 | 173.7754983181425 |
112 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2005 | 1.1289493669720014 | 1.6278733557445824 | 0.7446948170037049 |
113 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2005 | 18.70708837092546 | 20.2734000247444 | 17.046833373805715 |
114 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2006 | 0.4616221711952507 | 0.49978235825799183 | 0.40712836077075093 |
115 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2006 | 10.691684669959946 | 11.142950575679746 | 10.268987647328654 |
116 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2006 | 0.9826996772486054 | 1.1935882356442133 | 0.8223312697450411 |
117 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2006 | 0.7802526847374691 | 1.0908620276813719 | 0.5589972882089141 |
118 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2006 | 0.3874184763195336 | 0.5594401704506429 | 0.26964927002233224 |
119 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2006 | 4.856698608176363 | 9.617770246372283 | 2.060540159974443 |
120 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2006 | 4.335412951272399 | 5.634121299152482 | 3.2660719082141694 |
121 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2007 | 0.9709530071226171 | 1.1781524085919393 | 0.8066856191660593 |
122 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2007 | 0.7600882765438768 | 1.0546515773255434 | 0.5482283936506651 |
123 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2007 | 0.3777579049954043 | 0.5446905702416768 | 0.26437853061379873 |
124 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2007 | 4.73064643711179 | 9.356715464554924 | 1.9922736245671624 |
125 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2007 | 4.088558771986791 | 5.390408607019127 | 3.005622795910353 |
126 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2006 | 164.13474989868158 | 252.10318058437662 | 103.88375176826946 |
127 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2005 | 8.623290472663061 | 9.225336584127753 | 8.071930034556908 |
128 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2005 | 242.07420895462377 | 263.10708653404157 | 225.18057009906178 |
129 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2005 | 108.99039927416473 | 111.63156450018246 | 104.89107099396037 |
130 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2005 | 526.4872053063714 | 574.3318591002246 | 470.1456410562695 |
131 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2006 | 62.41235765274833 | 75.33443509626099 | 51.64133165197436 |
132 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2006 | 814.3647394592614 | 1713.753242558507 | 385.6237868665841 |
133 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2006 | 128.91383068160627 | 138.4214741688934 | 115.84238532164932 |
134 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2006 | 116.51259195562822 | 183.11566058024815 | 69.88437188232672 |
135 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2006 | 63.76001355610329 | 72.03051939506081 | 55.27086805147492 |
136 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2006 | 627.8358260680529 | 1372.1270189165593 | 103.49182602162844 |
137 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2007 | 64.33924030439566 | 77.90194843986477 | 53.23095796944748 |
138 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2007 | 822.5573110476878 | 1729.7495083733752 | 388.69563906394154 |
139 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2007 | 129.97151271763107 | 139.69312552886225 | 116.38237898051597 |
140 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2007 | 114.57193020746988 | 180.7749438521016 | 69.30651805528142 |
141 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2007 | 63.91689965351733 | 72.6494517142547 | 55.35201564221485 |
142 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2007 | 629.2635449942442 | 1377.6404923023663 | 104.17658212386813 |
143 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2005 | 1342.998352229417 | 1382.2653571697235 | 1275.515722959865 |
144 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2005 | 469.3195614477975 | 496.7007926199231 | 440.9892877650859 |
145 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2005 | 68.26817114235216 | 70.54274438392596 | 65.69626752813387 |
146 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2005 | 57.54109410311143 | 61.22698662943924 | 53.151317706376695 |
147 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2005 | 244.6304434984124 | 263.67725428366793 | 227.05233230412873 |
148 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2005 | 507.5449888761899 | 529.7906555237696 | 475.8663515076901 |
149 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2005 | 282.8226797363786 | 290.8730681750751 | 268.26101091310534 |
150 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2005 | 97.24433793009372 | 102.57066577691769 | 92.25688245633022 |
151 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2005 | 36.22253665822471 | 43.335663562170424 | 30.31976450666421 |
152 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2005 | 259.3989555762153 | 327.5614278653057 | 192.12798614228882 |
153 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2009 | 0.0 | 0.0 | 0.0 |
154 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2005 | 0.518828917614496 | 0.5607883630964363 | 0.4599361709324169 |
155 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2005 | 11.023014382346183 | 11.488734083037288 | 10.605491610373656 |
156 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2008 | 0.0 | 0.0 | 0.0 |
157 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2010 | 167.0526908542106 | 256.09761519623066 | 105.65175626332346 |
158 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2007 | 91.52545245611908 | 121.40131006146804 | 66.59562090733381 |
159 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2009 | 134.26976825511755 | 138.80869745334343 | 126.04682340024779 |
160 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2009 | 168.0053903405321 | 171.04915969572602 | 162.6659541555637 |
161 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2008 | 133.22285211221018 | 137.6013054098592 | 125.3480513981751 |
162 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2008 | 166.41470353320776 | 169.31618050545356 | 161.37087467675877 |
163 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2009 | 6.887696925630209 | 7.381266484152067 | 6.428802807839161 |
164 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2009 | 181.08496714949572 | 202.80161349427698 | 163.46866634006741 |
165 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2009 | 127.26210577887817 | 130.27116748421827 | 122.03784131942513 |
166 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2009 | 16.874945804353928 | 17.590463388814623 | 16.190003189618306 |
167 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2009 | 192.4231039038724 | 200.3303198018293 | 180.5305497526507 |
168 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2009 | 92.68620792233645 | 95.76130371193749 | 87.28270429085319 |
169 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2009 | 212.1688201592471 | 218.472742539141 | 201.07037554049242 |
170 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2009 | 1067.7830867327145 | 1151.8829268274812 | 972.7617639268929 |
171 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2009 | 1156.299672420146 | 1392.2533162703264 | 957.7780805476132 |
172 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2011 | 0.9415088241907927 | 1.1558335991017796 | 0.7780033533859263 |
173 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2011 | 0.7194653028752208 | 1.0058145910590752 | 0.5245520558470076 |
174 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2011 | 0.3574441354868962 | 0.5114045079764845 | 0.2531631205123234 |
175 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2011 | 4.323648550217614 | 8.678587823549943 | 1.8061164156808667 |
176 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2011 | 3.737396580283011 | 5.022735711640879 | 2.6838828499289513 |
177 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2008 | 1213.650576119767 | 1268.7615861897023 | 1135.8879937217632 |
178 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2008 | 360.9718184635058 | 507.95945007432766 | 248.76675958593881 |
179 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2008 | 513.0345360693717 | 522.6034062966313 | 499.42972814363657 |
180 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2008 | 16.781367553450664 | 17.473574143586603 | 16.1241102655615 |
181 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2008 | 193.8178246577256 | 201.2731078909237 | 182.03009018591456 |
182 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2008 | 92.98583819935538 | 95.99912706970599 | 87.83043951805578 |
183 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2008 | 212.8666710916033 | 218.92206537262342 | 202.08909632775772 |
184 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2008 | 1087.914055354145 | 1173.5012369679016 | 993.2861912243604 |
185 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2008 | 1148.482760586785 | 1376.4785417547928 | 954.8215258088675 |
186 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2005 | 364.10581349056457 | 455.71072296430395 | 286.74247640091687 |
187 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2005 | 754.4383918329011 | 856.0751822525468 | 648.3724503343961 |
188 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2005 | 876.9529548079435 | 1187.9276581135043 | 618.9559476274677 |
189 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2005 | 139.09745480302604 | 198.4021023949316 | 92.50087061626954 |
190 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2005 | 762.6400581927809 | 1028.7121197292934 | 522.994986035332 |
191 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2005 | 27.299466845571853 | 42.59701630884144 | 16.619553726178616 |
192 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2005 | 73.50605909500861 | 121.13197426237123 | 41.15613182279414 |
193 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2005 | 196.81424548973328 | 276.38638872319 | 137.0761066970044 |
194 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2005 | 21.442117827771945 | 35.39429100105454 | 11.49755821867114 |
195 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2008 | 7.313298236167356 | 7.852152608913061 | 6.832472238401347 |
196 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2008 | 196.15792955155433 | 217.8564816466888 | 178.67786426206018 |
197 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2008 | 120.47072302247297 | 123.38135536465829 | 115.6097339755107 |
198 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2009 | 1218.46310283674 | 1273.0718096295213 | 1138.7192348844987 |
199 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2009 | 378.5734158391303 | 532.7117924232625 | 261.34150884767075 |
200 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2009 | 522.6894374259674 | 532.034807137597 | 508.8037347237769 |
201 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2009 | 574.9932908658985 | 624.4898882716075 | 514.6778615891387 |
202 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2006 | 91.2826939747542 | 121.47175353398008 | 66.52308934844022 |
203 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2009 | 1300.588093473397 | 1340.6476373192363 | 1227.6013147668689 |
204 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2009 | 450.71400955055685 | 477.81194147925277 | 423.07909098189043 |
205 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2009 | 68.83343037441048 | 70.99212371099871 | 66.12491479474244 |
206 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2009 | 62.28229095330571 | 66.53045082245929 | 57.514965051416105 |
207 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2009 | 240.04815866184742 | 258.9580602686993 | 221.1829279991199 |
208 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2009 | 502.3599490149522 | 523.647798728143 | 472.18005325690046 |
209 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2009 | 298.9855656939848 | 307.5872449200612 | 282.68711849963114 |
210 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2009 | 99.71281437848683 | 105.38759270940605 | 94.17994619767755 |
211 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2009 | 39.29266721029395 | 47.27590451794634 | 33.06353428883558 |
212 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2009 | 263.3764147183684 | 333.35135670989615 | 196.43514642298052 |
213 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2008 | 560.2614169170897 | 608.0699550106317 | 502.03843504326926 |
214 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2011 | 70.73802720103434 | 85.16765497927048 | 58.841738339493595 |
215 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2011 | 866.0088067149562 | 1807.7944763301566 | 407.809991732431 |
216 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2011 | 138.71923410152965 | 149.40389100752716 | 123.71707783052076 |
217 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2011 | 109.96901839492325 | 174.8361442883034 | 68.70938671334305 |
218 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2011 | 64.41708998317814 | 72.88512530066917 | 55.51230309070878 |
219 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2011 | 636.8731722157947 | 1388.3470226869695 | 105.2555094738175 |
220 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2007 | 6.6772087238763564 | 9.025214740094341 | 4.696387514209271 |
221 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2008 | 62.827242722462906 | 80.01443084912438 | 47.898620678620915 |
222 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2008 | 395.22626971009976 | 793.4578881230475 | 191.75205022910023 |
223 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2008 | 1.000760691101569 | 1.4678792370054952 | 0.6577398647423585 |
224 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2008 | 17.93731208451399 | 19.487899585940642 | 16.40658056746974 |
225 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2005 | 602.1450933704178 | 827.0992390806663 | 421.35422353277426 |
226 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2009 | 0.4175322576117578 | 0.453065763759679 | 0.3628101716042227 |
227 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2009 | 10.453788569709664 | 10.900584392043012 | 10.04928473939549 |
228 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2008 | 1305.0518930822514 | 1344.2484980415038 | 1235.9018147383692 |
229 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2008 | 450.1204600399066 | 476.4938297028872 | 423.064478375452 |
230 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2008 | 68.67600113236362 | 70.86556229185406 | 66.09801200911693 |
231 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2008 | 60.76280636379386 | 64.78349972617654 | 56.104990473624085 |
232 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2008 | 241.00903650480376 | 259.67814491076734 | 222.03688059198797 |
233 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2008 | 505.21275888326556 | 526.6321686974721 | 474.1729925462879 |
234 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2008 | 294.40879435764026 | 303.01139048975807 | 278.7586513992344 |
235 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2008 | 96.89141982718948 | 102.35449240361724 | 91.63843245783897 |
236 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2008 | 38.56081413188002 | 46.53623368755146 | 32.40408819935068 |
237 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2008 | 262.31180439393694 | 332.01367529244453 | 196.21014537015841 |
238 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2006 | 6.671499078999879 | 9.078651011304933 | 4.661167397841388 |
239 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2008 | 0.42911038565976733 | 0.4649052653873846 | 0.37424364397431265 |
240 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2008 | 10.744225170424855 | 11.19537219385388 | 10.32357217818904 |
241 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2009 | 62.924558540624666 | 80.15325426233271 | 47.77335337349746 |
242 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2009 | 407.6390544099606 | 815.797740077406 | 198.0920075036184 |
243 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2009 | 0.9801224795900153 | 1.4350845663018044 | 0.6487389978121346 |
244 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2009 | 17.456755034132307 | 18.975221064045982 | 15.904853242708054 |
245 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2005 | 163.39413867639485 | 250.7805295730759 | 103.45185206714004 |
246 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2008 | 368.2457534798485 | 459.3000603312407 | 291.15043396846505 |
247 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2008 | 865.6960755432467 | 976.0207217277207 | 747.886663555355 |
248 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2008 | 879.831081078793 | 1194.9176012594053 | 623.8249160365892 |
249 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2008 | 139.37519769198718 | 197.9953353991688 | 91.67095176032011 |
250 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2008 | 737.0605904263173 | 994.5141604804784 | 504.06409903512576 |
251 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2008 | 26.92098485182652 | 41.717247316283384 | 16.42214114547438 |
252 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2008 | 72.4845807437847 | 119.72335627153468 | 40.42029319788128 |
253 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2008 | 195.83314015163708 | 273.8896194293853 | 136.05032715295462 |
254 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2008 | 21.077986577969803 | 34.93698826321783 | 11.364942279215809 |
255 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2011 | 93.28905793117308 | 124.02415764846972 | 67.99045195729684 |
256 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2009 | 369.5468712935468 | 460.98448212619144 | 292.1961749036074 |
257 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2009 | 900.9206547145914 | 1015.4337019206096 | 776.6394420049947 |
258 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2009 | 880.2245359642845 | 1193.8920297613595 | 624.4779286488701 |
259 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2009 | 139.41412098218868 | 199.26246938476208 | 91.96326731602579 |
260 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2009 | 729.6859568984887 | 985.8938952767014 | 499.4878274203514 |
261 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2009 | 26.804840113060838 | 41.83585375627087 | 16.318190953576245 |
262 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2009 | 72.1312420996046 | 119.40486431522172 | 40.40509159120721 |
263 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2009 | 195.44318289113744 | 273.4167090962122 | 136.14741516100318 |
264 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2009 | 20.96192600074563 | 34.60648856917355 | 11.293092624610674 |
265 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2008 | 0.9361901079766834 | 1.1415553117473922 | 0.7770607939610764 |
266 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2008 | 0.7443889754788736 | 1.036678977168625 | 0.536804384289365 |
267 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2008 | 0.36956910913193447 | 0.5296035412314773 | 0.261009750828011 |
268 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2008 | 4.572960405625224 | 9.096102609554523 | 1.931578675230311 |
269 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2008 | 3.9613056204910806 | 5.247280753068762 | 2.856685141178612 |
270 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2008 | 596.5680391131724 | 820.7990898078176 | 418.96357402286134 |
271 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2009 | 594.2789319323294 | 818.3276805041914 | 417.8292520608778 |
272 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2011 | 6.900571728644224 | 9.301021680964205 | 4.8736522402098785 |
273 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2010 | 0.9079879059485945 | 1.1140046983799492 | 0.7471927719685236 |
274 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2010 | 0.7213329077236756 | 1.0083657657488405 | 0.5225890837486025 |
275 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2010 | 0.35794619700685276 | 0.5150148685389387 | 0.25284164596673137 |
276 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2010 | 4.352810104238233 | 8.757329610241122 | 1.8246392525850699 |
277 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2010 | 3.801844055902835 | 5.072109747413022 | 2.727297661887807 |
278 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2009 | 0.9146133468339567 | 1.119773374180132 | 0.754750731265995 |
279 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2009 | 0.7326140460893569 | 1.015775053207582 | 0.5329785623504701 |
280 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2009 | 0.36343829436383335 | 0.5199637115151139 | 0.2574415016820723 |
281 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2009 | 4.431708736968568 | 8.87330709099871 | 1.854540001357761 |
282 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2009 | 3.8813060882876944 | 5.160228899027079 | 2.816411946654601 |
283 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2010 | 70.3492761715528 | 84.84275695337256 | 58.64823751003524 |
284 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2010 | 853.9907631942287 | 1784.5199848589882 | 402.6611126611878 |
285 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2010 | 135.7800797756277 | 146.03480195547863 | 120.9557986914855 |
286 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2010 | 110.78485474989347 | 181.65970119319329 | 67.75567802925497 |
287 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2010 | 64.0336648227211 | 72.8659642259743 | 55.30531367222453 |
288 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2010 | 634.3531504791007 | 1390.654971796655 | 104.66604047054975 |
289 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2008 | 66.62433569676568 | 80.50451988565985 | 55.09909483665831 |
290 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2008 | 833.0035577226643 | 1747.4547870899978 | 393.13882763673655 |
291 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2008 | 132.02138445871176 | 141.83465814539963 | 117.97862865255051 |
292 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2008 | 112.59294919345982 | 179.16153143074183 | 68.24910780356319 |
293 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2008 | 64.24366139559186 | 72.73074398381759 | 55.619225640810605 |
294 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2008 | 630.9050286176761 | 1382.824861800815 | 103.9912335661402 |
295 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2008 | 165.26050846140333 | 254.54112984065986 | 104.51673512026306 |
296 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2009 | 69.56550724167087 | 83.74918998952134 | 57.633702823040856 |
297 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2009 | 840.7806040210382 | 1759.9594243218144 | 396.1615404042775 |
298 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2009 | 133.39519181772746 | 143.33406607452267 | 119.49877848232754 |
299 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2009 | 111.67370758624726 | 179.73845758206443 | 67.67789886546346 |
300 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2009 | 64.4310652540117 | 73.07096798110011 | 55.733749867274526 |
301 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2009 | 632.845212626689 | 1386.2269987689806 | 104.35051472717753 |
302 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2009 | 165.91005657842942 | 255.22830537257173 | 105.06240375409352 |
303 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2008 | 91.78153243983475 | 121.83623905716937 | 66.59408102899629 |
304 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2010 | 92.70043432830542 | 122.6752028013784 | 67.48903495861609 |
305 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2009 | 92.16259591131254 | 122.2587111927906 | 67.2733888930789 |
306 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2013 | 0.0 | 0.0 | 0.0 |
307 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2012 | 0.0 | 0.0 | 0.0 |
308 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2013 | 125.85802652256935 | 130.3546847513162 | 118.07906801226643 |
309 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2013 | 173.2821908575861 | 176.60129158649434 | 167.6028886342484 |
310 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2008 | 6.688178630894049 | 9.083692877768332 | 4.688805180698408 |
311 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2012 | 6.263228997984375 | 6.7451334668387215 | 5.824932365995691 |
312 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2012 | 144.4906351118724 | 168.49454479463654 | 125.44226544040056 |
313 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2012 | 141.9529167063546 | 145.42860591207116 | 135.5403236884169 |
314 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2012 | 127.7606346437277 | 132.23780995545238 | 119.76922624838495 |
315 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2012 | 172.76038586671703 | 175.75783009740545 | 166.98149971242802 |
316 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2010 | 6.785569204278495 | 9.256101886394541 | 4.745418621329794 |
317 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2013 | 6.288232756957494 | 6.750943805531871 | 5.853019977650098 |
318 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2013 | 138.37640492388905 | 162.25986523596592 | 119.51696647333158 |
319 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2013 | 145.43540134749153 | 148.93599546440757 | 138.71469352513964 |
320 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2009 | 6.699846819042012 | 9.138121418422022 | 4.678375304034389 |
321 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2013 | 14.044953048388265 | 14.635474367390815 | 13.477959727062897 |
322 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2013 | 181.71744963214942 | 189.7831202597394 | 169.33108070834362 |
323 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2013 | 96.13307754788148 | 99.38427890842662 | 90.16310264135751 |
324 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2013 | 203.82507419966765 | 210.36151329090524 | 191.95919786699287 |
325 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2013 | 1062.7916633784948 | 1146.4500413656365 | 964.2433442986046 |
326 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2013 | 1200.6119241567312 | 1489.1347260065072 | 966.745721964395 |
327 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2012 | 1239.2760139034215 | 1278.6345215225288 | 1167.412517163963 |
328 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2012 | 438.591641109332 | 466.99286279207246 | 410.53753521141266 |
329 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2012 | 69.95697530981612 | 72.27097388594795 | 67.07496984395104 |
330 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2012 | 69.13460304207717 | 74.09493906865737 | 63.71407406192069 |
331 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2012 | 236.71848682429888 | 256.2090964802653 | 218.2289535854004 |
332 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2012 | 497.52106467204123 | 518.9381795290118 | 466.90260640308827 |
333 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2012 | 312.4816219263767 | 321.9968869299901 | 295.2044917324351 |
334 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2012 | 95.70495429667561 | 101.3471737918964 | 90.37549229092161 |
335 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2012 | 41.8068290181514 | 49.95518986536305 | 35.29849850843476 |
336 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2012 | 261.89428607620727 | 332.8767611166365 | 196.8561804529699 |
337 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2012 | 14.620912642505658 | 15.236671497757147 | 14.003092841681516 |
338 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2012 | 184.24879795257425 | 192.41902280736764 | 171.88936166196166 |
339 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2012 | 96.09897865110229 | 99.30444624441974 | 90.27387326340855 |
340 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2012 | 205.4733233898009 | 211.8682490668586 | 193.78427561826797 |
341 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2012 | 1058.0056369592787 | 1143.529604756972 | 959.7954746769627 |
342 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2012 | 1177.3289899570623 | 1450.2248816173346 | 954.450423031726 |
343 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2013 | 1221.783784590499 | 1262.8011161112724 | 1152.313145476954 |
344 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2013 | 433.0810184036504 | 460.35303176629947 | 406.0545573693206 |
345 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2013 | 71.02726183357493 | 73.40962298188342 | 68.21683684806617 |
346 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2013 | 71.59001564002439 | 76.64813314883978 | 66.01580329382664 |
347 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2013 | 237.63802630283223 | 256.63428316126993 | 218.45874011267637 |
348 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2013 | 497.48057274051746 | 520.1292000218378 | 466.634980097972 |
349 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2013 | 314.9421774494132 | 325.1175309200016 | 297.3508828447255 |
350 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2013 | 94.68911786760154 | 100.51680228810677 | 89.30070686662418 |
351 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2013 | 43.02916203678994 | 51.376485416187954 | 36.44786165409676 |
352 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2013 | 259.8399127971055 | 328.5517771493528 | 195.07370305406366 |
353 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2011 | 0.0 | 0.0 | 0.0 |
354 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2013 | 1275.1486369088536 | 1335.570104188556 | 1188.4711536192267 |
355 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2013 | 408.66987120738145 | 571.9880311936834 | 281.6420810570838 |
356 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2013 | 567.1148626182284 | 577.506844087667 | 551.4829806951068 |
357 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2011 | 128.7240376527783 | 133.20337732677837 | 120.94357272072445 |
358 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2011 | 169.5291462245863 | 172.7008123983362 | 164.19187461895285 |
359 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2013 | 728.5340483165493 | 783.2733598095454 | 661.7045960033196 |
360 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2012 | 687.5825948679613 | 740.8978328807026 | 622.0141458206135 |
361 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2011 | 6.564574849410273 | 7.034997214848052 | 6.112284025214372 |
362 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2011 | 152.39700854931712 | 176.05395951736025 | 133.45999746300208 |
363 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2011 | 137.9816827674341 | 141.32626486300123 | 131.99952632026498 |
364 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2012 | 379.563547131252 | 469.31336620904125 | 303.7997411556357 |
365 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2012 | 1060.7470321609992 | 1203.7757499272866 | 910.7684098517454 |
366 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2012 | 865.0210607889584 | 1172.3491507660835 | 615.0175516394223 |
367 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2012 | 139.34890782775034 | 198.01875230308806 | 92.28848484590291 |
368 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2012 | 685.4818373628398 | 926.2248614072712 | 469.0894485677294 |
369 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2012 | 26.438900601945345 | 40.877187138035715 | 16.198174167751006 |
370 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2012 | 68.56641739286033 | 114.18085160698719 | 38.340085535228496 |
371 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2012 | 194.7937867701996 | 272.16098378561367 | 136.04746741378116 |
372 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2012 | 20.48781875505115 | 34.094583080680955 | 11.115977260824653 |
373 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2013 | 384.40357462471036 | 475.0408032185296 | 308.6468510416989 |
374 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2013 | 1142.4237122863951 | 1298.672980167475 | 978.6422427515113 |
375 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2013 | 853.7437872983389 | 1153.3180319988817 | 605.9381297017372 |
376 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2013 | 139.26093270364865 | 198.94575865785384 | 92.09941027952539 |
377 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2013 | 663.429065069837 | 895.8761156113852 | 453.9451258139552 |
378 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2013 | 26.32445914695123 | 41.368648552058936 | 16.030348816397055 |
379 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2013 | 66.40606475692698 | 110.37509305099665 | 37.143974462321225 |
380 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2013 | 194.71225522044585 | 271.84474375644766 | 135.96792524451863 |
381 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2013 | 20.266958991231718 | 33.4375002529588 | 10.928961413538373 |
382 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2013 | 0.36522756245226323 | 0.39599349465565375 | 0.31590677410086904 |
383 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2013 | 9.525277597654936 | 9.996970871579054 | 9.124621207666461 |
384 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2012 | 0.3899662915968103 | 0.4223377591733324 | 0.33858555559479253 |
385 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2012 | 9.910471651778588 | 10.381425178297306 | 9.496322777040739 |
386 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2013 | 65.17133404146807 | 83.57117293646903 | 49.33350858024352 |
387 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2013 | 436.5372836327475 | 872.120117698456 | 213.0737391789348 |
388 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2013 | 0.9502741775974102 | 1.4016778601818753 | 0.6292073773105368 |
389 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2013 | 18.55374369761383 | 20.046234883443724 | 16.83797825005359 |
390 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2011 | 1249.751520638153 | 1289.1724816856051 | 1180.2096531448205 |
391 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2011 | 442.62160533326033 | 470.7772998203952 | 414.36609169640286 |
392 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2011 | 69.48257123104568 | 71.6953098254577 | 66.63064859910617 |
393 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2011 | 67.563307192723 | 72.22192700288451 | 62.50884649233459 |
394 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2011 | 238.58513881414027 | 257.65237937241614 | 220.01809049035492 |
395 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2011 | 499.0748426896327 | 520.1842616469613 | 468.7861228196516 |
396 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2011 | 306.8064400807415 | 316.21521490759363 | 290.16105986009626 |
397 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2011 | 96.85623949578077 | 102.33035635659643 | 91.40405585928944 |
398 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2011 | 40.748932517179206 | 48.98895416062393 | 34.24944933400801 |
399 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2011 | 263.38937332261077 | 334.069784843913 | 196.91678576320348 |
400 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2011 | 15.385803127781482 | 16.03693131058494 | 14.73727455580574 |
401 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2011 | 187.02284774875753 | 195.11643044333204 | 174.74719122640738 |
402 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2011 | 94.75986038508276 | 97.89381577884082 | 89.04897661709606 |
403 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2011 | 207.17824104341463 | 213.57478844626215 | 195.86979884906847 |
404 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2011 | 1057.4614408144791 | 1142.1693900470987 | 960.0296128037705 |
405 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2011 | 1155.987848223784 | 1414.7913587521714 | 943.310649367014 |
406 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2011 | 1243.1567484478908 | 1301.5765386844246 | 1158.2436796296045 |
407 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2011 | 395.85611561529987 | 556.6596532660941 | 273.5611931575143 |
408 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2011 | 544.3830197184903 | 554.2315515893916 | 529.404917246965 |
409 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2012 | 611.653959550674 | 843.4338770477508 | 428.6908031815261 |
410 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2015 | 0.0 | 0.0 | 0.0 |
411 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2010 | 6.823674439926282 | 7.3080176707436495 | 6.359744636902328 |
412 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2010 | 163.33200956825965 | 186.15442120237364 | 145.1116351561461 |
413 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2010 | 131.942226296202 | 135.34948663034152 | 126.24247895781299 |
414 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2010 | 0.0 | 0.0 | 0.0 |
415 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2012 | 1255.1408999194612 | 1315.1415988042352 | 1169.5899855001908 |
416 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2012 | 402.57201477625216 | 565.0528784107805 | 277.81574941989635 |
417 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2012 | 556.9848641695891 | 567.5297437607364 | 541.0361696298563 |
418 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2011 | 657.2386238439907 | 709.7943343184012 | 592.6242633172799 |
419 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2011 | 64.48119697054166 | 82.27636123210014 | 49.227243302759575 |
420 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2011 | 423.7437497785224 | 847.1647869694298 | 206.1906437893825 |
421 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2011 | 0.9529929699580357 | 1.4044492015935102 | 0.6324277282856293 |
422 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2011 | 17.6362994126596 | 19.10965959479386 | 15.964418235932046 |
423 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2010 | 1222.7402756913257 | 1279.0236490970747 | 1138.2466981200685 |
424 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2010 | 389.3565147199813 | 548.1610265296947 | 269.40407340434876 |
425 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2010 | 529.1913718891717 | 539.0021328569351 | 514.890441668508 |
426 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2013 | 620.4104641385852 | 854.7006126903019 | 434.42609552110173 |
427 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2014 | 0.0 | 0.0 | 0.0 |
428 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2012 | 171.25573954377234 | 263.5059167944274 | 108.40007657868874 |
429 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2010 | 129.32663491830294 | 134.12223407252552 | 121.55362153791185 |
430 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2010 | 166.95384744347962 | 170.0584434614487 | 161.59465899631405 |
431 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2012 | 64.89476849681083 | 82.91972495691799 | 49.379638389985104 |
432 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2012 | 430.18814961689264 | 859.3070775981332 | 209.6587451364993 |
433 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2012 | 0.9529661718970085 | 1.4019291153055005 | 0.6307408246178667 |
434 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2012 | 17.94534967629707 | 19.42165712061296 | 16.146763011227215 |
435 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2011 | 0.4070152003596777 | 0.4418591258624896 | 0.3524849170638041 |
436 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2011 | 10.146507184409625 | 10.59273361012176 | 9.741107841314893 |
437 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2010 | 1254.7017584360765 | 1293.6218052524152 | 1185.2367115319119 |
438 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2010 | 443.8220664175221 | 470.83462870132973 | 415.80087955030086 |
439 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2010 | 68.58122654610625 | 70.87687061676743 | 65.78342954764284 |
440 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2010 | 65.0593836140714 | 69.65089992524811 | 60.143433522201896 |
441 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2010 | 241.00229764017845 | 260.17407323702315 | 222.58560198414474 |
442 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2010 | 497.6279078600302 | 518.9172332847983 | 467.472999849344 |
443 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2010 | 302.40529905537375 | 311.3650099984166 | 285.87999978259427 |
444 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2010 | 98.11606490285419 | 103.75491869503975 | 92.64829815739387 |
445 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2010 | 39.917430027681355 | 48.182974282156266 | 33.44342870670371 |
446 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2010 | 263.8339988970679 | 334.23051672547314 | 198.28025877310435 |
447 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2015 | 122.00931199872224 | 126.63386752940278 | 114.61668625248419 |
448 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2015 | 178.03740391320608 | 181.3754699384706 | 171.9039892906888 |
449 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2011 | 376.8934923852398 | 468.05305265683484 | 300.53032130095346 |
450 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2011 | 997.4982958060083 | 1131.3475893172276 | 860.5275465070118 |
451 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2011 | 874.574749813869 | 1184.9512660477865 | 623.0719579263151 |
452 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2011 | 139.36517853666908 | 198.79931696384895 | 92.58466606205367 |
453 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2011 | 706.4776562488448 | 953.8934275491566 | 483.8575270533572 |
454 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2011 | 26.54359782158097 | 41.30741678311304 | 16.139093501284453 |
455 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2011 | 70.49241272019681 | 116.94017246365031 | 39.060217540091934 |
456 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2011 | 194.9031961613053 | 271.8155089771424 | 135.61045561191116 |
457 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2011 | 20.68398712987861 | 34.579976742158365 | 11.202931045297857 |
458 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2015 | 5.998823580980851 | 6.457647820101168 | 5.581458952167631 |
459 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2015 | 129.14062329440173 | 153.5423050268069 | 110.2390585285574 |
460 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2015 | 153.42601682614946 | 157.11009402270886 | 146.17489515350434 |
461 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2010 | 16.21277226145674 | 16.907512178582092 | 15.53697585188657 |
462 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2010 | 188.43609666297016 | 196.70262107074473 | 176.36552826349802 |
463 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2010 | 93.22421847645771 | 96.4023079198387 | 87.74646035898589 |
464 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2010 | 207.6944183818151 | 214.20693920078793 | 196.5854545986236 |
465 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2010 | 1055.388611643414 | 1139.1596291601945 | 958.9739521081875 |
466 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2010 | 1159.7151690955554 | 1405.844794628035 | 953.1758610410343 |
467 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2010 | 63.65688122562937 | 81.24161347595246 | 48.45897174159844 |
468 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2010 | 417.28628010547123 | 834.709392777112 | 202.85238665441614 |
469 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2010 | 0.9584722990093729 | 1.4099702278932433 | 0.6336631192394507 |
470 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2010 | 17.157705268801667 | 18.631272412450173 | 15.599128411698956 |
471 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2014 | 125.6579115274696 | 130.1526769321376 | 117.9429766405562 |
472 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2014 | 176.0994378168343 | 179.42975779215266 | 170.03546191595905 |
473 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2013 | 1.0008448886382928 | 1.2329180897525558 | 0.8263153450319873 |
474 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2013 | 0.7213993645392778 | 0.9897942146879508 | 0.5227567200638532 |
475 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2013 | 0.35624424565569235 | 0.5145329213605909 | 0.2509260225725204 |
476 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2013 | 4.289240532361176 | 8.55676028472706 | 1.790910112048374 |
477 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2013 | 3.682314838076013 | 4.97437631886464 | 2.632696239438503 |
478 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2015 | 13.230529822235972 | 13.803704382141037 | 12.668232931655048 |
479 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2015 | 180.0907894188891 | 188.3987910765294 | 167.57823899447314 |
480 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2015 | 98.21252292466968 | 101.5364635078985 | 92.03280596450523 |
481 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2015 | 198.2233835263343 | 204.3844146495054 | 186.3448164513949 |
482 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2015 | 1105.4733567938367 | 1193.1722221056555 | 1001.3510992176064 |
483 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2015 | 1284.9312512192503 | 1599.6931199051114 | 1030.067034102319 |
484 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2010 | 372.7167992249324 | 464.6750279027576 | 296.30844278227056 |
485 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2010 | 938.9461001147503 | 1062.7223966799177 | 808.9652073334216 |
486 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2010 | 879.3279596292678 | 1191.0914560322688 | 624.5480815629091 |
487 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2010 | 139.41583889244635 | 198.9978024535353 | 92.12721922577994 |
488 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2010 | 721.0530618483976 | 975.6794894065748 | 494.5122610916444 |
489 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2010 | 26.693753474539847 | 41.42515194739556 | 16.29871659032508 |
490 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2010 | 71.62360343506701 | 118.03401421907668 | 39.7903075181497 |
491 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2010 | 195.03878832334925 | 273.1025828650422 | 135.9025532965553 |
492 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2010 | 20.82658704802959 | 34.273320771333495 | 11.195891479665926 |
493 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2014 | 13.69756430674605 | 14.28685368523308 | 13.113788283466553 |
494 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2014 | 181.19756093102913 | 189.33459915476638 | 168.9239354913602 |
495 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2014 | 97.01993237025596 | 100.39106038161768 | 91.01563102224651 |
496 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2014 | 201.929781921334 | 208.41867437946595 | 190.05717420718474 |
497 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2014 | 1080.4903879146839 | 1166.38112948468 | 979.4367137486232 |
498 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2014 | 1239.8541677267945 | 1541.7800992744092 | 994.6923802911338 |
499 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2015 | 1174.005370105223 | 1217.9115434192456 | 1105.9423631132772 |
500 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2015 | 431.8084911364808 | 459.21641711484375 | 404.0759476077013 |
501 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2015 | 71.40857936414558 | 73.76175168959948 | 68.57964414963988 |
502 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2015 | 77.6384948458677 | 83.32748247408435 | 71.46464640801881 |
503 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2015 | 245.2996299588147 | 265.0051124574016 | 225.13734070360837 |
504 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2015 | 503.21635067725754 | 526.300554684354 | 472.2136434858979 |
505 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2015 | 329.0985509536536 | 339.9153121406691 | 310.6829044843577 |
506 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2015 | 87.82948659665843 | 93.11421815868736 | 82.67912971736365 |
507 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2015 | 46.217453944239224 | 54.931808029782026 | 39.26633995085826 |
508 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2015 | 255.94205395050076 | 322.48517276233775 | 191.77938342766487 |
509 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2013 | 69.44965644832283 | 83.14205488627067 | 58.15634412827659 |
510 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2013 | 888.9572123970516 | 1851.7540771603308 | 417.0589240998227 |
511 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2013 | 144.6736238893248 | 155.6234071397817 | 129.02328690113765 |
512 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2013 | 110.22273531817945 | 170.20716778212199 | 70.84637173315951 |
513 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2013 | 64.5973655256295 | 73.24503998697618 | 55.68740914008403 |
514 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2013 | 645.2217195560744 | 1406.7428972909631 | 105.51942209669107 |
515 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2010 | 601.951535551821 | 653.9704737496119 | 539.7046213105598 |
516 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2011 | 603.9206528327773 | 832.8569012492048 | 423.88565171943907 |
517 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2013 | 174.3634295706105 | 268.9377531121321 | 110.19790830970322 |
518 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2015 | 1313.1382936048412 | 1377.9768612615132 | 1222.8935271839375 |
519 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2015 | 415.79957683498105 | 582.3414338815722 | 285.51019840834823 |
520 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2015 | 585.1446874171047 | 596.7794635335873 | 568.5798443718251 |
521 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2015 | 790.0021367167755 | 847.7086834716898 | 721.3873265186453 |
522 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2014 | 1.0269784361245733 | 1.2722416180004532 | 0.8422816558843282 |
523 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2014 | 0.722813532422619 | 0.9947410303462143 | 0.526292844037921 |
524 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2014 | 0.35564190214142316 | 0.5145528040314379 | 0.25070188873658633 |
525 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2014 | 4.285641022954398 | 8.495552088525864 | 1.793164278633109 |
526 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2014 | 3.6815595068220337 | 4.962536593601532 | 2.622030717790313 |
527 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2014 | 758.1169006479623 | 814.8980063875714 | 691.070878968871 |
528 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2010 | 597.6215072590646 | 823.6787312698965 | 420.34107137723794 |
529 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2014 | 5.949486826153673 | 6.417700195945378 | 5.527433294563786 |
530 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2014 | 133.75028949183715 | 157.58539327159528 | 114.86059139961961 |
531 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2014 | 147.87546501223807 | 151.49789467185857 | 140.99319415939613 |
532 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2015 | 399.665312205805 | 491.5056604674224 | 325.00464958483104 |
533 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2015 | 1363.4778165292503 | 1552.9040387566567 | 1163.5509966949148 |
534 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2015 | 836.9633896843351 | 1129.6141493922462 | 592.3779302431969 |
535 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2015 | 139.0602529952661 | 199.16694853505402 | 92.57571937744727 |
536 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2015 | 638.2709815815623 | 860.8069370631642 | 435.9349509034995 |
537 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2015 | 26.123039592167526 | 40.90780687745999 | 16.03173650109607 |
538 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2015 | 63.45776151983585 | 104.42396662729155 | 35.18519014359752 |
539 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2015 | 194.4555932140041 | 270.9244071193155 | 136.3170554371105 |
540 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2015 | 19.89154199409705 | 32.71769903659592 | 10.743554814281861 |
541 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2012 | 0.9658158245740855 | 1.1888366542190711 | 0.7949781848341789 |
542 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2012 | 0.7190713372276288 | 0.9917460625858961 | 0.5213049350031085 |
543 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2012 | 0.35643399635290546 | 0.5102342807627819 | 0.2521655926761855 |
544 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2012 | 4.30226835450834 | 8.612610921325393 | 1.791451609220191 |
545 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2012 | 3.695400671684671 | 4.955159299977123 | 2.642399263501367 |
546 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2014 | 68.1844265641059 | 81.74220348422685 | 57.12276760782552 |
547 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2014 | 898.6520303370304 | 1872.7950183930204 | 421.3381748259163 |
548 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2014 | 147.98138845418094 | 159.27597906886592 | 131.9933253955337 |
549 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2014 | 110.44907110651923 | 169.0441633953882 | 71.65493239961191 |
550 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2014 | 65.12335075155224 | 73.78031295113625 | 56.05457989679016 |
551 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2014 | 648.3549735339282 | 1411.425300947473 | 106.18011813180365 |
552 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2015 | 65.83191665742741 | 84.80226976615552 | 49.781862332175635 |
553 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2015 | 449.4753138966692 | 898.620957459939 | 219.79568426942754 |
554 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2015 | 0.9604665249391952 | 1.4225726739534377 | 0.6278110240866303 |
555 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2015 | 20.493559842864045 | 21.980240384030573 | 18.665900369227202 |
556 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2015 | 0.3753983090652624 | 0.4071647588237743 | 0.32401608118535313 |
557 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2015 | 9.588830768839308 | 10.057111724598986 | 9.182977210700018 |
558 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2011 | 168.71790193379323 | 259.1793653954001 | 106.72887039417279 |
559 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2013 | 94.50661338616466 | 125.14490825972035 | 68.81465709975447 |
560 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2010 | 0.40571480571721463 | 0.4412619124132944 | 0.3503905485626678 |
561 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2010 | 10.257731221501942 | 10.698830448281516 | 9.846228506250034 |
562 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2014 | 1209.5334840872367 | 1252.5526623658595 | 1141.8827488418397 |
563 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2014 | 432.37917125859826 | 459.53686021278526 | 405.18065494153404 |
564 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2014 | 71.13064212123254 | 73.46798189466766 | 68.4283798408209 |
565 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2014 | 74.52389481428034 | 79.66902257507427 | 68.82335635060056 |
566 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2014 | 241.06371515608484 | 260.69739769418794 | 221.64821884895213 |
567 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2014 | 498.27197066839113 | 521.488243624209 | 468.1553028898496 |
568 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2014 | 322.03072662236855 | 332.52093784790395 | 304.21692960154587 |
569 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2014 | 92.28776109314147 | 97.83394409496493 | 86.94718357279022 |
570 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2014 | 44.827729488419 | 53.64484791140068 | 38.14958021945526 |
571 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2014 | 257.7074844335525 | 324.7368622472309 | 193.19899084885333 |
572 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2012 | 70.03929470858344 | 84.24456146743437 | 58.359183763558555 |
573 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2012 | 877.0074397014173 | 1828.9348747036838 | 411.95124243081705 |
574 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2012 | 141.40556486496345 | 152.23841543854158 | 126.11693187502834 |
575 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2012 | 110.27810859709126 | 172.58888365895496 | 70.90479821954688 |
576 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2012 | 64.45915977019907 | 72.73811676604511 | 55.52668530227491 |
577 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2012 | 641.0405367454811 | 1398.7457051952942 | 105.96480927691611 |
578 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2014 | 1284.6426112645047 | 1346.0941088364132 | 1198.709501030758 |
579 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2014 | 413.3439947635401 | 577.9383202201699 | 284.80097944530985 |
580 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2014 | 576.7494866490657 | 588.2319532732284 | 560.0967058745362 |
581 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2014 | 0.37044791735118376 | 0.40165817514164287 | 0.3190511955599388 |
582 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2014 | 9.70335034640122 | 10.182711773533471 | 9.293651485950907 |
583 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2018 | 69.11261698060143 | 82.40000984133505 | 58.07905100160193 |
584 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2018 | 958.3664633102893 | 1999.7233579909373 | 448.7544054807754 |
585 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2018 | 170.24646892516918 | 183.4916560339877 | 151.6480095315887 |
586 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2018 | 116.53063138891329 | 176.16447015475507 | 78.37267689012886 |
587 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2018 | 65.4023666531596 | 74.28214771593856 | 56.52908815346469 |
588 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2018 | 644.6884391826803 | 1404.599895701888 | 105.70841432040248 |
589 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2015 | 637.2721377940427 | 875.3802745123686 | 444.4625134296453 |
590 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2013 | 7.230399665413767 | 9.817780820935623 | 5.039760877176878 |
591 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2014 | 390.37309718750544 | 481.63543570331626 | 315.63998969838843 |
592 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2014 | 1242.263968692031 | 1417.119887438385 | 1061.2870852727358 |
593 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2014 | 843.6451634456045 | 1137.4198138842467 | 598.3800546606119 |
594 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2014 | 139.16383677076527 | 199.6929101762658 | 92.96737771652693 |
595 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2014 | 646.0567458146937 | 871.822708279494 | 442.0299604893072 |
596 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2014 | 26.24575878032457 | 41.090613463107275 | 16.041965796710883 |
597 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2014 | 64.54044950757068 | 106.72750278338562 | 35.926865624301 |
598 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2014 | 194.63188560039964 | 271.57586341460393 | 135.6233174124808 |
599 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2014 | 20.070761873652717 | 33.21558144643323 | 10.84170188841893 |
600 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2012 | 93.94534071725631 | 124.77645255605175 | 68.30902793000212 |
601 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2014 | 65.39568419274471 | 83.63665923653613 | 49.59447094944238 |
602 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2014 | 442.629852116476 | 884.2381002118992 | 216.0139486529332 |
603 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2014 | 0.9468568865992625 | 1.3982735269560995 | 0.6204739808272538 |
604 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2014 | 19.429932776834455 | 20.967960549927003 | 17.67344511132584 |
605 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2014 | 95.02747230970394 | 125.99939760665738 | 69.27402483598362 |
606 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2017 | 1.077586676483608 | 1.3346903984153053 | 0.8833006637306535 |
607 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2017 | 0.710335279751485 | 0.9701536165593467 | 0.5123968188356951 |
608 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2017 | 0.3510677814072916 | 0.5029358613700627 | 0.2517525217496964 |
609 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2017 | 4.3084348025262065 | 8.50818434074239 | 1.8040929822436402 |
610 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2017 | 3.791885825573287 | 5.030712251194357 | 2.7513907100676485 |
611 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2015 | 181.09920376350811 | 280.2437964110756 | 114.46971967351601 |
612 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2012 | 7.048481481118079 | 9.553082030033073 | 4.965337675753151 |
613 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2017 | 69.0444887054559 | 82.38283299301837 | 57.97867268001484 |
614 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2017 | 941.616205190867 | 1963.0223432897526 | 439.7045432297887 |
615 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2017 | 164.70953476565649 | 177.5072275591224 | 147.09876316827726 |
616 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2017 | 114.44799705926619 | 171.74431102726385 | 75.4446217895531 |
617 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2017 | 66.00883319043572 | 74.7737275632235 | 57.165735706429864 |
618 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2017 | 646.1175913474775 | 1406.70592217257 | 106.18907790558185 |
619 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2018 | 97.37726926741631 | 129.06970954217175 | 71.24473375310001 |
620 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2014 | 628.4077208215613 | 865.1939237826454 | 439.105838992648 |
621 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2014 | 7.400397876680719 | 10.04280351559865 | 5.217257572984116 |
622 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2017 | 96.80582327908306 | 128.4621113662172 | 70.6678795187842 |
623 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2018 | 8.443169259225643 | 11.517024220213326 | 5.973459531504261 |
624 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2019 | 0.0 | 0.0 | 0.0 |
625 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2016 | 1.0598203324661182 | 1.3167514773837345 | 0.8676809258824967 |
626 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2016 | 0.7181259873641552 | 0.9766093281473924 | 0.5228973854040508 |
627 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2016 | 0.3539280226316634 | 0.5127869578806842 | 0.2522721496979731 |
628 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2016 | 4.300524106754385 | 8.520269241350347 | 1.8037871066949198 |
629 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2016 | 3.7117440604401954 | 4.962579301954696 | 2.653516964206164 |
630 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2019 | 116.39405548915448 | 121.1177959478749 | 109.12474489176952 |
631 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2019 | 178.55613428555966 | 182.40890675429762 | 172.4620960258422 |
632 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2017 | 8.124476952019046 | 11.00841645611882 | 5.70100722425344 |
633 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2014 | 177.67347490809524 | 274.4871793361393 | 112.30743690255423 |
634 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2016 | 68.51280276422926 | 81.71542447719308 | 57.47706501143761 |
635 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2016 | 926.7245654561862 | 1930.330891039846 | 433.30907801754256 |
636 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2016 | 158.34638563673218 | 170.63759568226922 | 141.15532723870606 |
637 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2016 | 112.91147923134875 | 171.583024013379 | 73.51715948196286 |
638 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2016 | 66.05762852512169 | 74.82980912061099 | 56.995243352710254 |
639 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2016 | 647.477006298896 | 1411.2771335608786 | 106.74508656986636 |
640 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2019 | 11.3198592426509 | 11.835007033048564 | 10.779710953295327 |
641 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2019 | 175.40993386815708 | 183.585313505213 | 163.30710054698912 |
642 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2019 | 97.89279389976582 | 101.76867781240037 | 91.51037042777212 |
643 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2019 | 192.13097285155058 | 198.64299342075427 | 180.19982153478037 |
644 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2019 | 1150.4379134459307 | 1240.5864243603871 | 1040.197870343641 |
645 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2019 | 1443.4267903995474 | 1795.3356528547733 | 1152.1756692511085 |
646 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2018 | 0.0 | 0.0 | 0.0 |
647 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2015 | 1.0425545467813946 | 1.2931405358373536 | 0.853770884206954 |
648 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2015 | 0.7199986405168608 | 0.982410268081051 | 0.5238759314148892 |
649 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2015 | 0.35442076290094127 | 0.5151992262681452 | 0.25017838992948194 |
650 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2015 | 4.290618993637059 | 8.471973015073921 | 1.7923207690781198 |
651 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2015 | 3.6865974428514723 | 4.960322024227016 | 2.6498003032371904 |
652 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2017 | 0.0 | 0.0 | 0.0 |
653 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2019 | 863.3934273650344 | 922.1013949704995 | 791.9092954337086 |
654 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2016 | 96.2119197269514 | 127.26119621703168 | 70.39248472314364 |
655 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2015 | 68.2893626559421 | 81.80560068170776 | 57.54766725740545 |
656 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2015 | 913.8770940793505 | 1904.2114554150446 | 427.36095650853633 |
657 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2015 | 152.77727213390716 | 164.6068831007961 | 136.66266659919836 |
658 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2015 | 111.5979717110945 | 170.5389791709414 | 72.25804606137511 |
659 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2015 | 65.5723727821452 | 74.64312635601269 | 56.63702436134433 |
660 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2015 | 648.7302136223516 | 1412.9738820935434 | 106.60927195904098 |
661 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2018 | 119.3394113836243 | 124.08990759770681 | 111.65475549422983 |
662 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2018 | 179.53545176887044 | 183.10076526290536 | 173.4866804112361 |
663 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2019 | 6.797436238666905 | 7.275675507406433 | 6.34930181198113 |
664 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2019 | 110.94631245977607 | 135.85931640570286 | 91.03760705654847 |
665 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2019 | 167.46278758042624 | 171.83105221518346 | 159.27506701787928 |
666 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2017 | 122.25888047738255 | 126.77679908969543 | 114.61989045925621 |
667 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2017 | 180.58413266065565 | 183.95519991497906 | 174.03600183474714 |
668 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2019 | 0.3789809900709466 | 0.4262848035692505 | 0.3120509773125585 |
669 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2019 | 9.030840316696967 | 9.497199173249006 | 8.625682357619077 |
670 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2019 | 1354.9173012035264 | 1432.4365758787994 | 1261.008443737438 |
671 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2019 | 421.7591622463123 | 594.7022920656474 | 288.4951116963221 |
672 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2019 | 579.0662820105565 | 592.2422567346023 | 562.2898541056418 |
673 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2016 | 7.829346072788063 | 10.645255433682665 | 5.507919304675257 |
674 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2015 | 95.62361201244666 | 126.42035083376061 | 69.79154871675946 |
675 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2019 | 1065.695078205337 | 1109.2799491101182 | 1000.3416714914594 |
676 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2019 | 422.3835346299296 | 449.68801810508876 | 393.5377480933887 |
677 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2019 | 66.31320250899388 | 68.72774144526267 | 63.697691796720314 |
678 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2019 | 88.1909740557288 | 94.74464697570988 | 81.61875359535705 |
679 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2019 | 263.02092725142154 | 285.6061550240264 | 241.04980383570012 |
680 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2019 | 499.1477063817416 | 523.2313276494734 | 467.03801388804897 |
681 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2019 | 348.0094444199434 | 360.32062618070245 | 326.74169430820444 |
682 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2019 | 78.07591828200671 | 82.95792541199516 | 73.35899199239634 |
683 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2019 | 48.362042398642934 | 57.67588674958917 | 40.830123059099584 |
684 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2019 | 249.1247790885082 | 315.7106471916379 | 186.85423693593577 |
685 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2017 | 12.106663493427874 | 12.622077094278527 | 11.547295060397431 |
686 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2017 | 179.56147658992424 | 187.67098081479352 | 167.08765205570592 |
687 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2017 | 98.31159159879813 | 101.90830667678283 | 92.06522337790088 |
688 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2017 | 197.09976909492698 | 203.60890324345624 | 185.19464473685443 |
689 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2017 | 1144.0135911079876 | 1232.3908137958817 | 1034.7397229256737 |
690 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2017 | 1365.540204238503 | 1701.9781134905893 | 1092.0413762294215 |
691 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2018 | 6.604115001298952 | 7.079883489473963 | 6.177897696197344 |
692 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2018 | 114.56689405742371 | 139.17620303229276 | 95.26453569981145 |
693 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2018 | 166.62831618282752 | 170.7313194338303 | 158.2986471760781 |
694 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2018 | 11.825658770249687 | 12.35976086852603 | 11.268056815536267 |
695 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2018 | 176.64515358486094 | 184.8326258185976 | 164.05501426412172 |
696 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2018 | 97.52848661123879 | 101.17877220254853 | 91.1397748526729 |
697 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2018 | 194.34023814087033 | 200.79871967711975 | 182.3313923445226 |
698 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2018 | 1145.3720983068968 | 1233.976953706481 | 1034.0406734218254 |
699 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2018 | 1401.547734940492 | 1745.2475798712974 | 1119.8214016826753 |
700 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2019 | 66.47659451485626 | 85.69876891950837 | 49.82362537571673 |
701 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2019 | 491.29153537060654 | 990.5643139333592 | 238.48993363266638 |
702 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2019 | 1.0707532155215038 | 1.614924794356214 | 0.6643225358639511 |
703 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2019 | 21.740888860906434 | 23.412789703238083 | 19.733545734055078 |
704 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2017 | 835.4670108912505 | 895.7791280250586 | 765.1292860883674 |
705 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2018 | 1354.6307703736163 | 1428.5466870083717 | 1258.6929865647912 |
706 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2018 | 419.536620510866 | 589.6097379110859 | 287.2038331646357 |
707 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2018 | 576.6250490629214 | 589.6860799897138 | 558.930065723277 |
708 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2019 | 427.4642593413358 | 517.6860331395314 | 353.8953812839798 |
709 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2019 | 1815.7347334913538 | 2068.93785501502 | 1546.4542892768354 |
710 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2019 | 831.3831509810044 | 1129.9348224574035 | 586.0416583200077 |
711 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2019 | 138.65081118411842 | 197.28685678078241 | 92.50097786642388 |
712 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2019 | 705.0982839520475 | 949.6344453589751 | 486.9548900594522 |
713 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2019 | 26.161903976907045 | 40.64020888620298 | 15.949468516470377 |
714 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2019 | 62.53465584596052 | 103.81315256786979 | 35.049822659983306 |
715 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2019 | 192.69134366788097 | 269.11060750833263 | 134.35129632473485 |
716 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2019 | 19.792906544582987 | 33.157773031937225 | 10.517331196272554 |
717 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2015 | 7.60032494847383 | 10.39850495675351 | 5.366437231702894 |
718 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2018 | 1085.9864203298516 | 1127.630587892636 | 1020.4640611094669 |
719 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2018 | 425.35043871402314 | 452.19423194371547 | 396.0417874885249 |
720 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2018 | 67.29296604994973 | 69.6368563648703 | 64.63240184275479 |
721 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2018 | 86.69858649837128 | 93.03759715380238 | 80.10100948904865 |
722 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2018 | 259.7422934512956 | 280.81794919057364 | 237.5116527781514 |
723 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2018 | 501.6794314099654 | 525.8882444552573 | 469.53230852041946 |
724 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2018 | 343.1689168192252 | 355.0782832800343 | 322.23334265300025 |
725 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2018 | 79.25440890453017 | 84.07387392284731 | 74.47492957540962 |
726 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2018 | 48.113423412492196 | 57.35123213171213 | 40.84682413100813 |
727 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2018 | 250.37336338912792 | 317.12012566441877 | 187.85642875978021 |
728 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2016 | 0.0 | 0.0 | 0.0 |
729 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2018 | 845.5861305764412 | 905.0754034509226 | 775.3489253671797 |
730 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2018 | 423.08586844521494 | 513.5042373806654 | 349.53695394489 |
731 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2018 | 1733.9950374245595 | 1972.9247245633348 | 1479.5275031971414 |
732 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2018 | 830.4593766214615 | 1127.8487857772 | 587.2969466460595 |
733 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2018 | 138.6867424570034 | 197.54912197124042 | 92.13976652664242 |
734 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2018 | 694.2857241892375 | 936.2873227334375 | 478.6294179046129 |
735 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2018 | 26.182238473019332 | 40.87415905707375 | 15.943429172673502 |
736 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2018 | 62.74121533580776 | 103.84229135673522 | 35.20496131512438 |
737 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2018 | 193.1104912885873 | 269.0081634943479 | 134.61512038836423 |
738 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2018 | 19.842200834610956 | 32.99730230565244 | 10.653472196223872 |
739 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2016 | 123.57902945324419 | 127.97622593053934 | 115.78262064671087 |
740 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2016 | 181.5142741746269 | 184.90015754920012 | 174.90646484285068 |
741 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2017 | 0.3892536187882409 | 0.4292079920132792 | 0.33317924822683825 |
742 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2017 | 9.53410112639875 | 10.02309809966619 | 9.121668911402955 |
743 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2017 | 1352.7001092877401 | 1423.3701001787251 | 1259.3438761103685 |
744 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2017 | 418.76955737668254 | 587.4064379998041 | 287.6261626894655 |
745 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2017 | 580.6972844803405 | 593.942087985638 | 563.7749506322863 |
746 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2018 | 66.42493519854072 | 85.82284740120386 | 49.81001769384353 |
747 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2018 | 479.36526974632824 | 965.6236221452892 | 232.31356849585657 |
748 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2018 | 1.028247948961738 | 1.531741433844548 | 0.6489067714846204 |
749 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2018 | 21.5712491783 | 23.10509631213562 | 19.651334437515384 |
750 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2017 | 6.321181700382839 | 6.788471567373992 | 5.892073158280189 |
751 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2017 | 117.91898582925533 | 141.88711698750004 | 98.74811116574122 |
752 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2017 | 165.05458441525238 | 169.01282135637362 | 156.84171422441628 |
753 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2018 | 0.3638661417811905 | 0.4052562207067313 | 0.3056816501681012 |
754 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2018 | 9.262619311679833 | 9.71937758696995 | 8.853499791391293 |
755 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2016 | 12.412679514432298 | 12.956959550325086 | 11.860280870071199 |
756 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2016 | 180.77118710635037 | 188.99716899551467 | 168.21832624584422 |
757 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2016 | 98.77567151330717 | 102.17881796876497 | 92.52936990072652 |
758 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2016 | 199.27488211744878 | 205.7606744770327 | 187.2860945362298 |
759 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2016 | 1129.0320344779525 | 1217.0817189155425 | 1021.9020584643193 |
760 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2016 | 1325.6965663451372 | 1652.7265466057352 | 1063.0108241768394 |
761 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2016 | 818.2512542655505 | 877.2294430010239 | 749.071419937848 |
762 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2020 | 0.0 | 0.0 | 0.0 |
763 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2016 | 0.39847286211348 | 0.4352693954557953 | 0.34661886775341866 |
764 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2016 | 9.717071315721856 | 10.217784676062507 | 9.299769545202281 |
765 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2020 | 116.87963702426069 | 122.07894301114483 | 109.4839240453253 |
766 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2020 | 178.07527029236374 | 182.31689059444867 | 170.99806261534644 |
767 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2017 | 66.58910340331356 | 85.86405518584687 | 50.31983335102661 |
768 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2017 | 467.72287168223806 | 942.245045191532 | 227.68333471975726 |
769 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2017 | 0.9895609090411 | 1.4742291187896779 | 0.627345964233696 |
770 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2017 | 21.721414451706192 | 23.24341790609378 | 19.681184300567658 |
771 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2017 | 1121.3817267153825 | 1163.5471825479235 | 1057.4063329326175 |
772 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2017 | 430.51684286054376 | 457.63185824600225 | 401.8005098627219 |
773 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2017 | 69.5995362276715 | 71.952743383919 | 66.80475647494886 |
774 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2017 | 85.50476435472892 | 91.94209009288878 | 78.8589266734774 |
775 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2017 | 256.02721875385475 | 276.39407534084177 | 234.21969762467697 |
776 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2017 | 507.6418467484218 | 531.4346320187881 | 476.8653856081707 |
777 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2017 | 341.75491195714636 | 353.0315715449432 | 322.1226176406888 |
778 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2017 | 81.02862166686586 | 85.87769850246245 | 76.26180516167442 |
779 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2017 | 47.45554861257697 | 56.47425037550134 | 40.41130254801847 |
780 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2017 | 252.42413829356926 | 318.6005404219763 | 189.47152930465865 |
781 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2020 | 11.230977733044682 | 11.767265764647897 | 10.66493931062455 |
782 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2020 | 177.01421792085742 | 185.9110661676564 | 164.52057301645436 |
783 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2020 | 99.0234663416352 | 103.09857785141588 | 92.23359138157274 |
784 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2020 | 192.29043692057553 | 199.25517802535114 | 179.50811771529771 |
785 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2020 | 1147.8896727239246 | 1239.510586851285 | 1037.1220284264743 |
786 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2020 | 1482.8024459529393 | 1848.5105984502595 | 1179.500260301543 |
787 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2020 | 877.083004519668 | 941.5762986034728 | 800.8190622049426 |
788 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2019 | 668.360781694573 | 918.7241277700869 | 465.6687537332062 |
789 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2020 | 0.3660565993392008 | 0.41486605229671664 | 0.2966267449436812 |
790 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2020 | 8.83796038340102 | 9.322686580605776 | 8.444874999851947 |
791 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2018 | 659.8243480365292 | 905.8796967965185 | 459.98719028341964 |
792 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2017 | 420.38394791282343 | 510.66026716985147 | 345.7817587117963 |
793 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2017 | 1649.2519626331318 | 1869.5377957789688 | 1413.2120869978364 |
794 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2017 | 831.3452550716444 | 1125.7116289291744 | 588.2092010813444 |
795 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2017 | 138.83112182774383 | 197.76457581843852 | 92.48425300883017 |
796 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2017 | 671.1295104088424 | 905.1324694536286 | 461.8618954508141 |
797 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2017 | 26.16647312050673 | 40.99281442983689 | 15.926144041273346 |
798 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2017 | 62.86528241323104 | 104.22225723242147 | 35.431549526889874 |
799 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2017 | 193.60168031122353 | 269.7037832373368 | 135.31617767868488 |
800 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2017 | 19.83007594253752 | 32.67249478548193 | 10.707665551949454 |
801 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2016 | 1333.0332692642637 | 1400.8267701254701 | 1244.0283174155943 |
802 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2016 | 417.5456055539966 | 584.7944088120242 | 286.64872750039933 |
803 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2016 | 584.531007567036 | 596.7398063680308 | 567.9146784082316 |
804 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2018 | 195.93595834704007 | 304.2150698531618 | 123.06904045629084 |
805 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2016 | 66.24555144882353 | 85.03837706391006 | 50.14825028928558 |
806 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2016 | 457.46260053354683 | 916.6506342469537 | 223.1001112727001 |
807 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2016 | 0.9719416113468778 | 1.4335307695440853 | 0.6294230830652368 |
808 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2016 | 21.49378474682933 | 22.98892928810827 | 19.625962323116873 |
809 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2019 | 198.52187069189145 | 306.88271166106676 | 124.59504519955848 |
810 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2016 | 6.23156705878473 | 6.685759549843437 | 5.811266587942143 |
811 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2016 | 123.89584270968294 | 148.05672096217396 | 104.7892335079739 |
812 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2016 | 161.5430765976677 | 165.40361671081914 | 153.98184222454105 |
813 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2016 | 1153.6712669888032 | 1197.2442848891076 | 1087.9548402187381 |
814 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2016 | 433.2538928589742 | 460.81697457884957 | 404.67790976787086 |
815 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2016 | 70.99080756625526 | 73.4620792810762 | 68.16188336445103 |
816 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2016 | 83.00737836074563 | 89.27333147077044 | 76.5330414920006 |
817 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2016 | 253.6973090413828 | 273.6933480500174 | 232.16057906604578 |
818 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2016 | 509.1200106026747 | 532.6569365604767 | 478.64379245550344 |
819 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2016 | 337.5914446160022 | 348.6668603426938 | 318.5982680172518 |
820 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2016 | 83.72014683027786 | 88.71654456228093 | 78.6749611591529 |
821 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2016 | 46.71328765211047 | 55.435973724370804 | 39.78689645517907 |
822 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2016 | 254.36623324775633 | 321.5071460114324 | 189.80494528664926 |
823 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2017 | 651.8663497038748 | 893.4933823009337 | 454.6570596229512 |
824 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2020 | 1370.2831251756008 | 1449.7308580567874 | 1272.118985151245 |
825 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2020 | 422.5408527284171 | 600.8187346905767 | 287.84535824197303 |
826 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2020 | 576.0321687961454 | 590.7500829268057 | 556.8008647284239 |
827 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2016 | 412.7226064273284 | 504.21346279271967 | 338.40314427716083 |
828 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2016 | 1514.1325128645447 | 1716.535122359317 | 1301.3881063125011 |
829 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2016 | 833.7660423716807 | 1127.4564522843878 | 591.1589502319466 |
830 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2016 | 138.94049548238482 | 197.9404634111657 | 92.20794149012646 |
831 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2016 | 648.3183116335962 | 874.7443530546877 | 444.5496570847071 |
832 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2016 | 26.121477665948696 | 40.93090505532155 | 15.933160352304608 |
833 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2016 | 63.086868875930925 | 104.2370328404155 | 35.2387076167153 |
834 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2016 | 194.0620016222121 | 271.39021369790726 | 135.45214436483417 |
835 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2016 | 19.819508649395573 | 32.65101810547746 | 10.67822912817368 |
836 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2020 | 67.14680359508135 | 86.66509499557114 | 50.46578177980806 |
837 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2020 | 507.81118412314225 | 1027.4593640557061 | 246.76475314786535 |
838 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2020 | 1.2773968898414618 | 2.004643081706877 | 0.7688108069378534 |
839 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2020 | 21.554889380030374 | 23.721607823484856 | 19.4525340128627 |
840 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2017 | 190.96903499625984 | 296.95912905963337 | 120.00873775896162 |
841 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2020 | 6.717033328854323 | 7.178401048787988 | 6.288841158934156 |
842 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2020 | 114.08403163233648 | 139.84914241897826 | 93.97251078850238 |
843 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2020 | 169.67473231040694 | 174.81111721021807 | 160.08115513948832 |
844 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2018 | 1.037699567467934 | 1.295063937228827 | 0.8456521298870202 |
845 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2018 | 0.7023690280713398 | 0.9615922862064198 | 0.504516225688949 |
846 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2018 | 0.345603966129631 | 0.49660887191603764 | 0.24782551787370902 |
847 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2018 | 4.316817264607645 | 8.494456413199334 | 1.8075627142984867 |
848 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2018 | 3.963163910962455 | 5.221065104375857 | 2.953349133834196 |
849 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2016 | 644.4868455613065 | 882.9127331440548 | 449.15445392559803 |
850 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2020 | 1073.0954973236526 | 1117.0494859424246 | 1003.698190158885 |
851 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2020 | 422.5466301050384 | 451.40577599023356 | 393.1004281667673 |
852 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2020 | 65.67003905326632 | 68.09379101873839 | 62.73152741463994 |
853 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2020 | 88.9272850535322 | 95.5260360840674 | 81.67406700877581 |
854 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2020 | 267.5623209404681 | 290.3901467098798 | 244.64862047473787 |
855 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2020 | 500.69547545660583 | 525.2325253412706 | 468.5133673234992 |
856 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2020 | 351.13220616983466 | 363.88815096304006 | 329.0834558425505 |
857 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2020 | 78.23696131930049 | 83.30985704324017 | 73.46756495860193 |
858 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2020 | 48.9777943354216 | 58.70557152980196 | 41.25016380679981 |
859 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2020 | 248.71992705425237 | 313.66316682356654 | 186.04689641442306 |
860 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2019 | 1.0438546544389011 | 1.2998740808603266 | 0.8487388351840272 |
861 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2019 | 0.6955518472515324 | 0.9521048958583592 | 0.4961751337444128 |
862 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2019 | 0.3422231276330385 | 0.491212684136842 | 0.24491600584292467 |
863 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2019 | 4.32801826872545 | 8.526988084419862 | 1.8129565802412126 |
864 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2019 | 4.128916613939808 | 5.3602336511672934 | 3.1234324799090074 |
865 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2020 | 419.31063048504996 | 508.5760375650405 | 348.6383246691148 |
866 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2020 | 1918.438482811292 | 2207.9986827301045 | 1627.7409418749032 |
867 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2020 | 1031.1583505921128 | 1384.3480488730468 | 725.6866842487565 |
868 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2020 | 138.24563722998644 | 197.77827423430116 | 91.7292178545383 |
869 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2020 | 834.1062753160537 | 1122.8948575892614 | 569.3807013092963 |
870 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2020 | 25.84630674201089 | 40.96180570049134 | 15.730448641423214 |
871 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2020 | 61.86578901424456 | 102.85501934598933 | 34.61341741603659 |
872 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2020 | 192.15187416459278 | 268.72246948988516 | 133.578427807532 |
873 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2020 | 19.636429714066708 | 33.18974850236938 | 10.646304814125374 |
874 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2016 | 185.46741702199 | 287.4890719639421 | 116.98400363219439 |
875 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2019 | 69.95602187572521 | 83.17099748357313 | 58.879005592022985 |
876 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2019 | 972.3521196006604 | 2033.5012538665296 | 455.3660792317548 |
877 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2019 | 176.07453975465094 | 189.54163593970114 | 157.23911329111078 |
878 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2019 | 117.31787431374788 | 180.66632357712757 | 78.98748533264452 |
879 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2019 | 65.26854200854544 | 73.86676006236235 | 56.39867522461935 |
880 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2019 | 643.6575534094816 | 1400.7580897612693 | 106.25570632713769 |
881 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2020 | 677.4610503754088 | 927.5091485305971 | 474.11925261352866 |
882 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2019 | 97.87100885451697 | 129.38929964991962 | 71.42046249546915 |
883 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2020 | 186.9769878892989 | 283.99575447060374 | 119.41409494602331 |
884 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2019 | 8.675169813695966 | 11.85057398191507 | 6.073888146098677 |
885 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2020 | 1.051630712606121 | 1.3134517308448566 | 0.8501962491687881 |
886 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2020 | 0.6861779530010955 | 0.9408453639803631 | 0.4919215284152113 |
887 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2020 | 0.33651006808082595 | 0.4828501558118578 | 0.23880250247247362 |
888 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2020 | 4.332124680560595 | 8.57276460641521 | 1.8131467074772467 |
889 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2020 | 4.0992611525070695 | 5.354614303890044 | 3.109836605048496 |
890 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2020 | 70.05809652239051 | 83.49344691131623 | 58.898042752311 |
891 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2020 | 986.1066426881516 | 2065.8643692745172 | 461.0860034480616 |
892 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2020 | 179.15025144301933 | 192.91342388434254 | 159.849478243937 |
893 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2020 | 115.90051625264091 | 171.9249909365034 | 74.21234505594336 |
894 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2020 | 65.29992211086665 | 73.8363745216274 | 56.24487294907811 |
895 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2020 | 640.8621809333561 | 1393.9038073986176 | 106.24495334170163 |
896 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2020 | 98.10798604196027 | 129.72099338349696 | 72.07183175271219 |
897 | 2 | DALYs (Disability-Adjusted Life Years) | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2020 | 8.749111469006268 | 11.9579870409937 | 6.087146250947132 |
898 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2005 | 117.52256919699 | 126.79385360604 | 108.86561403829 |
899 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2006 | 118.50640828195999 | 127.82233399695001 | 109.81967580126 |
900 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2007 | 119.35540825582999 | 128.70222253736 | 110.56511455416 |
901 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2008 | 120.11387317366999 | 129.48208124545002 | 111.23249898162 |
902 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2009 | 120.81938866462 | 130.21004000647 | 111.81695301169 |
903 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2010 | 121.47672494509001 | 130.89249515260002 | 112.4359132726 |
904 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2011 | 122.07173340841001 | 131.60077358806 | 113.00613324012001 |
905 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2012 | 122.58264428778 | 132.21003136509 | 113.50143675932999 |
906 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2013 | 123.0387792349 | 132.76897038614 | 113.91995185769 |
907 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2014 | 123.47087692356001 | 133.23976957361998 | 114.34448912327001 |
908 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2015 | 123.88794701566 | 133.62780070441002 | 114.76705001746001 |
909 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2016 | 124.22970047324 | 134.07955807889 | 115.04329966186 |
910 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2017 | 124.43209720528 | 134.39434832049 | 115.02532323277 |
911 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2018 | 124.61955031268 | 134.64135574103 | 115.00112827214998 |
912 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2019 | 124.91374013853999 | 134.98352903081 | 115.19028288713999 |
913 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 546 | Multiple sclerosis | 3 | Rate | 2020 | 125.41101505931 | 135.6585619861 | 115.72292049762999 |
914 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2005 | 16685.18872356415 | 19125.23176902935 | 14405.61858725441 |
915 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2006 | 16702.80044713183 | 19158.34211337033 | 14404.133329166649 |
916 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2007 | 16737.07706087839 | 19197.785246698808 | 14454.26679091201 |
917 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2008 | 16783.56678794784 | 19228.16981765507 | 14559.24738247139 |
918 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2009 | 16839.52708664743 | 19336.96529790861 | 14617.75973016122 |
919 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2010 | 16881.428202516017 | 19440.472787500392 | 14626.47431085859 |
920 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2011 | 16968.101637991782 | 19492.51468287524 | 14745.55187074087 |
921 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2012 | 17114.01505840641 | 19686.2591696421 | 14883.300694535128 |
922 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2013 | 17270.81488394748 | 19796.8696307272 | 15018.447215391001 |
923 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2014 | 17394.09008351439 | 19954.90107684218 | 15159.148118294419 |
924 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2015 | 17426.31621682939 | 19991.18208763189 | 15138.54131677761 |
925 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2016 | 17407.144133497222 | 19964.33715597917 | 15119.97121701611 |
926 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2017 | 17388.0109660734 | 19937.26490745796 | 15101.452681532759 |
927 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2018 | 17369.24335498706 | 19909.76512681128 | 15082.448251897049 |
928 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2019 | 17353.81171751591 | 19887.45333346587 | 15067.701848281931 |
929 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 547 | Migraine | 3 | Rate | 2020 | 17337.56395262919 | 19870.87157127339 | 15058.03769334476 |
930 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2005 | 25.34536775267 | 25.79521904051 | 24.77827902274 |
931 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2006 | 24.82336472594 | 25.32056265628 | 24.216455643819998 |
932 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2007 | 24.83505623313 | 25.328624229080003 | 24.24140190059 |
933 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2008 | 25.2392718031 | 25.76017654087 | 24.62235762141 |
934 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2009 | 25.685809101260002 | 26.22216482556 | 25.06967901087 |
935 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2010 | 25.51137812044 | 26.09186861002 | 24.893644788779998 |
936 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2011 | 25.90716326194 | 26.507608345260003 | 25.26101952743 |
937 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2012 | 26.33895004051 | 26.92480903303 | 25.626384787950002 |
938 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2013 | 26.163098011429998 | 26.743434992980003 | 25.45280253072 |
939 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2014 | 26.16084025133 | 26.77752533395 | 25.37918560584 |
940 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2015 | 26.2608368693 | 26.83101435895 | 25.473596036380002 |
941 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2016 | 26.642453112410003 | 27.17875417951 | 25.916355911400004 |
942 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2017 | 26.29103651527 | 26.83004655102 | 25.53154955942 |
943 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2018 | 26.040987999699997 | 26.63375279996 | 25.21319422633 |
944 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2019 | 25.73491800884 | 26.32407807282 | 24.929005533869997 |
945 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 477 | Brain and central nervous system cancer | 3 | Rate | 2020 | 25.44932841521 | 26.15427544207 | 24.57742161558 |
946 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2005 | 411.07046432282 | 483.55014240734005 | 346.63027322056996 |
947 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2006 | 412.5492288005 | 484.44403730676 | 347.60614253542 |
948 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2007 | 414.27688091385 | 485.89595144630005 | 348.55037964535 |
949 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2008 | 416.09227076643 | 487.94874250636997 | 349.50551775251 |
950 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2009 | 417.80611037163 | 489.97560361169997 | 350.37072956932 |
951 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2010 | 418.83344525113 | 491.18076304628994 | 350.67120791548 |
952 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2011 | 418.56297289072995 | 490.37333963531995 | 350.99108336278 |
953 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2012 | 416.63075486328 | 487.72766919015004 | 350.02909820127 |
954 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2013 | 413.82376197691 | 484.17190528701 | 348.33573742018996 |
955 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2014 | 411.00304519119 | 480.84371878459 | 346.96021135185003 |
956 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2015 | 408.65210176748997 | 478.57775766808 | 345.5495320315 |
957 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2016 | 406.68359220025 | 476.10357651069 | 343.54941312741 |
958 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2017 | 404.30655417604 | 473.37348859238006 | 341.33801037762 |
959 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2018 | 402.01331817760996 | 470.93645994361003 | 339.4030048464 |
960 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2019 | 400.37966772637003 | 469.26642541813004 | 338.04659834986 |
961 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 559 | Schizophrenia | 3 | Rate | 2020 | 401.34055355786 | 470.12328958081 | 338.80026870174004 |
962 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2005 | 2073.94750015523 | 2364.91109939449 | 1847.7286064434402 |
963 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2006 | 2111.38197993401 | 2407.3682595606697 | 1883.09006313003 |
964 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2007 | 2157.84953352937 | 2455.5805332811697 | 1926.17509259022 |
965 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2008 | 2210.86995776444 | 2510.17769619271 | 1974.7391574804499 |
966 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2009 | 2268.73145274777 | 2572.49711326838 | 2027.30128171174 |
967 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2010 | 2325.78413385877 | 2631.73220824049 | 2081.8334517803996 |
968 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2011 | 2398.9895213813998 | 2710.3960330786 | 2151.10366675084 |
969 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2012 | 2496.6104090261397 | 2806.29101392627 | 2240.81941316552 |
970 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2013 | 2608.14996576887 | 2925.80778064033 | 2349.6579107599 |
971 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2014 | 2724.5817147605303 | 3052.23239063867 | 2459.9175017870602 |
972 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2015 | 2833.15332764995 | 3160.86524410538 | 2556.29957814716 |
973 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2016 | 2952.66115235633 | 3280.7916297893903 | 2671.66949434711 |
974 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2017 | 3090.00481405643 | 3438.2941801476504 | 2793.62005923851 |
975 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2018 | 3222.82523654891 | 3580.9135075668996 | 2918.3325831506 |
976 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2019 | 3329.64520812535 | 3695.7182876679803 | 3014.62224531359 |
977 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 561 | Drug use disorders | 3 | Rate | 2020 | 3629.2473686020803 | 4004.48266889589 | 3304.4160582035497 |
978 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2005 | 8.28904270778 | 8.58398327352 | 7.8655353982700005 |
979 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2006 | 8.4508224464 | 8.74911927494 | 8.00255427021 |
980 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2007 | 8.636309754200001 | 8.94783971049 | 8.155722359359999 |
981 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2008 | 8.77362607135 | 9.10073949566 | 8.26151993745 |
982 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2009 | 9.047446039919999 | 9.38758287884 | 8.47730455878 |
983 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2010 | 9.37010372648 | 9.732980333070001 | 8.7743921052 |
984 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2011 | 9.5053027035 | 9.86892979363 | 8.89181159234 |
985 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2012 | 9.52712215156 | 9.8991896943 | 8.89594872694 |
986 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2013 | 9.372868565440001 | 9.72693340352 | 8.74092672224 |
987 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2014 | 9.3283137088 | 9.69482457741 | 8.6948913238 |
988 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2015 | 9.36919202647 | 9.729396332310001 | 8.71600622005 |
989 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2016 | 9.349295328310001 | 9.69353647605 | 8.70133881362 |
990 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2017 | 9.19115442256 | 9.54573496931 | 8.54683629948 |
991 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2018 | 9.02575137221 | 9.38064781209 | 8.38602084076 |
992 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2019 | 9.01466205475 | 9.40111499928 | 8.36072797856 |
993 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 486 | Multiple myeloma | 3 | Rate | 2020 | 9.06985271824 | 9.46076703841 | 8.42386624342 |
994 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2005 | 2411.62063852468 | 2766.2683678231 | 2085.51251395455 |
995 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2006 | 2417.89932609772 | 2772.83822274454 | 2094.2245166611197 |
996 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2007 | 2420.87402727935 | 2777.80301084946 | 2098.3197170284798 |
997 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2008 | 2422.6158034238 | 2776.63325188939 | 2099.67016113303 |
998 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2009 | 2425.05497077785 | 2781.82396342325 | 2103.48053997754 |
999 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2010 | 2426.63890505238 | 2785.23389315612 | 2108.41641442193 |
1000 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2011 | 2427.46800936331 | 2780.61583932857 | 2115.44791915007 |
1001 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2012 | 2425.49154890313 | 2772.25646949242 | 2117.0207987364497 |
1002 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2013 | 2421.46637979745 | 2764.53445006747 | 2116.62733190886 |
1003 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2014 | 2417.10487369321 | 2755.46515140514 | 2109.54964103554 |
1004 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2015 | 2411.7661750236 | 2751.06341295013 | 2099.52958834058 |
1005 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2016 | 2411.30739685469 | 2751.80821303412 | 2103.0493076334496 |
1006 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2017 | 2414.9599397780003 | 2759.73913253542 | 2109.1976143127004 |
1007 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2018 | 2417.58603140204 | 2769.2897620282897 | 2111.28102176897 |
1008 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2019 | 2414.0055933647 | 2765.7549617598 | 2107.93265747032 |
1009 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 560 | Alcohol use disorders | 3 | Rate | 2020 | 2365.05495284272 | 2696.03537149379 | 2069.72096610866 |
1010 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2005 | 1798.09111304663 | 1890.85972124206 | 1721.36343440736 |
1011 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2006 | 1792.85899614981 | 1884.97403454647 | 1717.2118909537799 |
1012 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2007 | 1778.27291419782 | 1868.6069015145902 | 1703.9565780480398 |
1013 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2008 | 1761.0169089615401 | 1848.54864057757 | 1687.91403429518 |
1014 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2009 | 1745.39607051218 | 1830.06940568467 | 1673.1282348196899 |
1015 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2010 | 1743.78065309291 | 1826.8441034365 | 1671.6287699811 |
1016 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2011 | 1748.37752493473 | 1834.27216079841 | 1675.1274128952502 |
1017 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2012 | 1754.82588160799 | 1841.1455047575498 | 1680.96468109547 |
1018 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2013 | 1763.05217259696 | 1850.4626425581198 | 1688.21213241536 |
1019 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2014 | 1770.55962806093 | 1859.83633981184 | 1693.4148262563099 |
1020 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2015 | 1782.4072356930499 | 1874.07710703217 | 1701.5997607545698 |
1021 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2016 | 1793.9709323128598 | 1888.9768827323498 | 1711.01392033556 |
1022 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2017 | 1807.7640653478202 | 1903.4822428516202 | 1718.6245074829899 |
1023 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2018 | 1822.05507239477 | 1924.1566696685302 | 1724.20360734163 |
1024 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2019 | 1832.87207602543 | 1942.07476990873 | 1726.1183130972101 |
1025 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 494 | Stroke | 3 | Rate | 2020 | 1826.9224416193701 | 1943.7162605281499 | 1721.2378006349502 |
1026 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2005 | 6504.67287193856 | 7493.97775395469 | 5626.36529875474 |
1027 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2006 | 6422.10918896137 | 7406.83764320124 | 5570.1633030446 |
1028 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2007 | 6353.673220907349 | 7323.04088201983 | 5516.94421231025 |
1029 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2008 | 6293.19783720534 | 7238.13697768748 | 5468.13693091099 |
1030 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2009 | 6233.505947730359 | 7163.70753782323 | 5419.34211101675 |
1031 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2010 | 6162.30758014484 | 7066.414112438691 | 5366.01272911565 |
1032 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2011 | 6041.27046498398 | 6924.99802788217 | 5264.83140087229 |
1033 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2012 | 5865.1677914209495 | 6723.305466791479 | 5112.03900024254 |
1034 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2013 | 5680.3444109427 | 6518.81225788294 | 4943.72721998364 |
1035 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2014 | 5534.4917037206005 | 6352.780164076869 | 4810.063944180431 |
1036 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2015 | 5473.30020020852 | 6271.215270727119 | 4754.5384560449 |
1037 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2016 | 5565.61858002 | 6375.265793103491 | 4835.3217780131 |
1038 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2017 | 5771.384381827021 | 6599.712955940259 | 5022.11180335818 |
1039 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2018 | 5979.98366308118 | 6840.1833844816 | 5218.2430099655 |
1040 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2019 | 6080.52098557204 | 6968.29468973231 | 5311.24221595056 |
1041 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 571 | Anxiety disorders | 3 | Rate | 2020 | 7195.42922628496 | 8276.346869692059 | 6186.4049156829 |
1042 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2005 | 126.12350697878999 | 174.03373206764 | 86.20301493485 |
1043 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2006 | 125.67989047900001 | 173.44932931121 | 85.89631624602 |
1044 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2007 | 125.14378166161 | 172.70470944477 | 85.54802183132 |
1045 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2008 | 124.55153590742 | 171.84968254186 | 85.26873539473 |
1046 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2009 | 123.98318267127001 | 171.12630678911 | 85.25605728370999 |
1047 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2010 | 123.33358430969 | 170.26961997024 | 84.90160778906 |
1048 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2011 | 122.76497759681 | 169.31656743325 | 84.50701546252 |
1049 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2012 | 122.25788380423 | 168.30626598791 | 84.13351643982 |
1050 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2013 | 121.79180930634999 | 167.50654598109 | 83.76060259887 |
1051 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2014 | 121.40771805691001 | 167.44279102529 | 83.39783265009 |
1052 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2015 | 121.00126952295 | 166.45557070991 | 82.99659434654 |
1053 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2016 | 120.92733452892001 | 166.75326575937999 | 82.8806309606 |
1054 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2017 | 121.19304653327 | 167.23741221206 | 82.94524153516 |
1055 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2018 | 121.45376103647001 | 167.30355771599 | 83.12769495054 |
1056 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2019 | 121.42540009336001 | 167.19981444336 | 83.22491818811 |
1057 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 573 | Anorexia nervosa | 3 | Rate | 2020 | 120.38468291479 | 166.42327903476 | 82.17090491362 |
1058 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2005 | 1764.68010420897 | 2429.01527539172 | 1294.91386525918 |
1059 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2006 | 1755.13122501167 | 2420.3489485709 | 1298.92925685861 |
1060 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2007 | 1745.26052308782 | 2398.85974974572 | 1287.15837475104 |
1061 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2008 | 1735.51574728423 | 2386.27909000743 | 1278.44186210795 |
1062 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2009 | 1726.43616510798 | 2382.48046215072 | 1279.19895965892 |
1063 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2010 | 1716.0659985342102 | 2359.33783487747 | 1269.90788698053 |
1064 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2011 | 1703.6534083456502 | 2356.94828048316 | 1255.60205612397 |
1065 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2012 | 1688.05779167358 | 2350.45836224883 | 1243.09801851073 |
1066 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2013 | 1670.8746286178603 | 2329.19130943914 | 1224.56627566721 |
1067 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2014 | 1654.3836512507698 | 2307.1356436137403 | 1211.76145478902 |
1068 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2015 | 1640.2598976034299 | 2287.10282152499 | 1203.7389999571 |
1069 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2016 | 1634.4850920128802 | 2283.46885426095 | 1200.30426194364 |
1070 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2017 | 1635.53985592833 | 2280.6935932250803 | 1199.54955346526 |
1071 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2018 | 1636.8795364167102 | 2277.32014101909 | 1188.15670460545 |
1072 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2019 | 1632.6786308624899 | 2280.38096561613 | 1187.13164025933 |
1073 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 578 | Attention-deficit/hyperactivity disorder | 3 | Rate | 2020 | 1621.6837540275 | 2253.70692174699 | 1173.40658657079 |
1074 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2005 | 4885.45591328931 | 5387.92464292862 | 4429.05808692593 |
1075 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2006 | 4884.42610386812 | 5394.7306775056795 | 4442.89677222148 |
1076 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2007 | 4874.47458310323 | 5383.52473055954 | 4443.48865712172 |
1077 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2008 | 4860.727781186671 | 5372.79973682101 | 4439.91495738972 |
1078 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2009 | 4848.73552313706 | 5369.8674063868 | 4429.66707649918 |
1079 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2010 | 4839.4266464434895 | 5356.27381531093 | 4419.14513546705 |
1080 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2011 | 4833.89676682783 | 5340.59679579567 | 4416.94967125533 |
1081 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2012 | 4827.3106150127605 | 5314.103032357851 | 4412.06259829891 |
1082 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2013 | 4819.32707719037 | 5282.19325941867 | 4396.587831947199 |
1083 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2014 | 4810.10107251072 | 5266.1368019946 | 4394.5129059978 |
1084 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2015 | 4797.36082555991 | 5266.76518654498 | 4385.8630191006405 |
1085 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2016 | 4785.4534157094 | 5244.31191138727 | 4381.45491034923 |
1086 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2017 | 4777.7722436333 | 5241.95587537245 | 4376.20176042961 |
1087 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2018 | 4776.67563613729 | 5267.16816253313 | 4376.36257892557 |
1088 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2019 | 4784.74207379372 | 5287.778293403509 | 4377.37256409384 |
1089 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 567 | Depressive disorders | 3 | Rate | 2020 | 5764.79038129815 | 6393.3562872147 | 5220.70444620716 |
1090 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2005 | 7678.077894209149 | 8126.14634301547 | 7275.332549683159 |
1091 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2006 | 7931.68846867444 | 8388.46367189654 | 7513.68300877619 |
1092 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2007 | 8191.02329213868 | 8655.611795404091 | 7767.397700664259 |
1093 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2008 | 8461.56642780485 | 8934.734734520871 | 8034.0916039378 |
1094 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2009 | 8746.29840479186 | 9231.758474915561 | 8304.82009204138 |
1095 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2010 | 9074.21573161402 | 9573.7566116189 | 8627.32052076534 |
1096 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2011 | 9454.52855136544 | 9974.970779011861 | 8987.16997296312 |
1097 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2012 | 9903.127923212369 | 10457.63339703701 | 9413.04990724191 |
1098 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2013 | 10385.39960015886 | 10973.35597540752 | 9866.51866474254 |
1099 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2014 | 10862.19279235812 | 11479.14538773822 | 10309.33200921282 |
1100 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2015 | 11316.73304478799 | 11964.74869820309 | 10727.42487662001 |
1101 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2016 | 11722.336508752509 | 12389.1905923469 | 11116.96001065128 |
1102 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2017 | 12118.94597777857 | 12812.97618097625 | 11498.561132724371 |
1103 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2018 | 12523.00793727674 | 13246.08819106316 | 11884.80264097487 |
1104 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2019 | 12949.452223171858 | 13720.41649186123 | 12275.80235115088 |
1105 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 587 | Diabetes mellitus | 3 | Rate | 2020 | 13440.024853606841 | 14236.193896324039 | 12727.02306555108 |
1106 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2005 | 19163.062829614068 | 22327.73252700459 | 16344.75542018473 |
1107 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2006 | 18987.68579062319 | 22147.4878568958 | 16155.98970092441 |
1108 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2007 | 18497.954405910692 | 21615.90981827853 | 15687.454479350441 |
1109 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2008 | 17884.39899661624 | 20928.349684900062 | 15136.23931205907 |
1110 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2009 | 17334.91122291117 | 20310.711897085588 | 14658.59610459103 |
1111 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2010 | 17037.12524101482 | 19977.219182267792 | 14400.77039478346 |
1112 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2011 | 16940.6503484266 | 19812.73507365711 | 14312.630898082709 |
1113 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2012 | 16872.59588375659 | 19677.82699320107 | 14261.23490686374 |
1114 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2013 | 16836.90728126152 | 19614.62660097775 | 14225.11703732656 |
1115 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2014 | 16836.69508662978 | 19639.90513883959 | 14212.01932796731 |
1116 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2015 | 16875.014491390488 | 19691.67173145652 | 14241.44693093642 |
1117 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2016 | 16932.787106583542 | 19766.88441926559 | 14268.28331041126 |
1118 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2017 | 16987.63730192818 | 19840.15220314667 | 14290.642873967548 |
1119 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2018 | 17042.858981887322 | 19916.85064446977 | 14317.20875028084 |
1120 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2019 | 17101.507507165912 | 19996.138539337422 | 14353.97399540361 |
1121 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 398 | Genital herpes | 3 | Rate | 2020 | 17151.52891086086 | 20126.11750305 | 14464.82259693436 |
1122 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2005 | 4977.084531128769 | 5187.95192272469 | 4747.79369560712 |
1123 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2006 | 5011.04489351532 | 5220.513347036989 | 4782.14334965546 |
1124 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2007 | 5048.2146566993 | 5256.35505507757 | 4822.49654307666 |
1125 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2008 | 5092.9941650598 | 5300.26993813364 | 4865.83910641932 |
1126 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2009 | 5133.2011158838095 | 5338.67549471808 | 4907.73521313638 |
1127 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2010 | 5187.71747936099 | 5395.75692296439 | 4963.24558717279 |
1128 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2011 | 5238.58915046793 | 5450.24200035094 | 5009.80677824314 |
1129 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2012 | 5303.051178661461 | 5521.92599697969 | 5066.72784429474 |
1130 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2013 | 5375.44567179597 | 5603.727091595069 | 5132.1460009517805 |
1131 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2014 | 5441.21059116933 | 5674.25343695148 | 5192.556861066 |
1132 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2015 | 5518.045982216449 | 5754.51545271905 | 5262.92775118998 |
1133 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2016 | 5588.24758006282 | 5831.4063816387 | 5327.15885058334 |
1134 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2017 | 5672.82069908644 | 5920.5968131698 | 5402.65588888955 |
1135 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2018 | 5766.94659639583 | 6022.49736286247 | 5483.4254602258 |
1136 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2019 | 5859.9821302073005 | 6118.47625900598 | 5570.59408752524 |
1137 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 509 | Chronic obstructive pulmonary disease | 3 | Rate | 2020 | 5952.4299460222 | 6207.85156093165 | 5661.01054719654 |
1138 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2005 | 61.77136814469 | 71.79970308557999 | 53.74411558789 |
1139 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2006 | 61.99719516156 | 71.9595068107 | 53.95558662347 |
1140 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2007 | 62.18496051374 | 72.08591336542 | 54.14422592817 |
1141 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2008 | 62.46837690352 | 72.36701667787001 | 54.336710611399994 |
1142 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2009 | 62.78956354944 | 72.68353791194001 | 54.656355828360006 |
1143 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2010 | 63.65823767492999 | 73.65570450697 | 55.42257504496 |
1144 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2011 | 64.8588947674 | 75.00242435677 | 56.45410698802 |
1145 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2012 | 66.54111996825999 | 76.86702890789 | 57.89311337822 |
1146 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2013 | 68.59150058719 | 79.17027482766 | 59.657832633599995 |
1147 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2014 | 70.55035911213 | 81.50599450077 | 61.348612472250004 |
1148 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2015 | 72.65792121643 | 83.95384528459999 | 63.17991798328 |
1149 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2016 | 74.84411787619 | 86.236597075 | 65.12702063752 |
1150 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2017 | 77.58858474476 | 89.32150103907 | 67.53535809924 |
1151 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2018 | 80.51439826265 | 92.70052292305999 | 70.09866890373 |
1152 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2019 | 82.7700144884 | 95.43818278095 | 71.8532738831 |
1153 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 670 | Glaucoma | 3 | Rate | 2020 | 83.78468594623999 | 96.65491276298 | 72.92636453629 |
1154 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2005 | 350.6252311532 | 498.66927631502 | 235.01612254479 |
1155 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2006 | 348.86131462298005 | 495.17070276562 | 234.01904048774998 |
1156 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2007 | 347.29633660751 | 492.72157609608996 | 233.13475886498 |
1157 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2008 | 345.72157208434004 | 490.09896360331 | 231.1708984609 |
1158 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2009 | 344.03868526888 | 487.11592659872 | 229.08106708933 |
1159 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2010 | 341.63206427755 | 482.99012349145005 | 226.50642440959 |
1160 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2011 | 336.31609849138 | 476.39374362512 | 223.09335968202998 |
1161 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2012 | 327.30853520520003 | 464.52029464525 | 218.18704507132998 |
1162 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2013 | 317.11581227219 | 450.81468641644 | 211.77007629144 |
1163 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2014 | 308.32198260359996 | 437.45854609537 | 205.74938616789998 |
1164 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2015 | 303.21041368402996 | 429.36664101585 | 201.82862312122003 |
1165 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2016 | 301.61557700867 | 427.14116995852 | 200.29924246482003 |
1166 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2017 | 300.88490353077 | 426.98864919873006 | 199.27788042573 |
1167 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2018 | 300.39429622355 | 425.90905841593997 | 198.21248707827 |
1168 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2019 | 299.61163658898 | 424.81682759383 | 197.82918607279 |
1169 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 574 | Bulimia nervosa | 3 | Rate | 2020 | 297.42041635461 | 422.45075195743 | 195.25382818709 |
1170 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2005 | 471.12115346081 | 594.4661779386801 | 365.33022383482 |
1171 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2006 | 465.19205745677004 | 587.13692899056 | 360.91105915818997 |
1172 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2007 | 453.21041722648 | 572.2251725638899 | 351.51735859331 |
1173 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2008 | 439.33405507629 | 554.83953865868 | 340.40285662464 |
1174 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2009 | 427.55736394829 | 539.8374696265599 | 331.04059211068 |
1175 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2010 | 421.18499285256 | 531.168648176 | 326.05644717477 |
1176 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2011 | 419.22859800565 | 528.20697870821 | 324.88386852268 |
1177 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2012 | 417.25351707923005 | 524.64655743949 | 323.70745253263004 |
1178 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2013 | 415.37752535335994 | 521.16052250853 | 322.59489133034003 |
1179 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2014 | 413.65145988109003 | 517.88255334358 | 321.5154553645 |
1180 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2015 | 411.47888705073 | 514.64991321286 | 320.07268014271 |
1181 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2016 | 408.14182669272 | 511.15719801838003 | 317.96026466615996 |
1182 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2017 | 403.35648008425994 | 506.29720369935 | 314.58289554533997 |
1183 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2018 | 398.6988164677 | 500.82695853132 | 311.1804097072 |
1184 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2019 | 395.89596249778003 | 497.49578277844006 | 309.08318075885 |
1185 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 394 | Syphilis | 3 | Rate | 2020 | 395.31636217288 | 496.67097548413005 | 308.31273157336 |
1186 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2005 | 160.63803534049 | 206.5212744762 | 123.64303378129999 |
1187 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2006 | 160.19418269278 | 206.46220547244 | 123.09942451158001 |
1188 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2007 | 159.71578063789 | 206.11779148219998 | 122.63184689846 |
1189 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2008 | 159.27666871432 | 205.82074164571 | 122.42877520986 |
1190 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2009 | 158.91933948204 | 205.99307508483 | 122.29260595609001 |
1191 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2010 | 158.36080927311 | 205.93219248160997 | 121.93220356036001 |
1192 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2011 | 157.77457745046 | 205.18058888522 | 121.50362906727 |
1193 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2012 | 157.11801618196 | 204.16486155964 | 120.48499792146 |
1194 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2013 | 156.42834419464 | 202.71589310686 | 119.52509343564002 |
1195 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2014 | 155.78715899306 | 201.55871353577 | 119.3728027731 |
1196 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2015 | 155.05839759071 | 200.25747281368 | 119.0416679565 |
1197 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2016 | 158.39974193671 | 204.66253850729 | 122.04899688523 |
1198 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2017 | 166.53507873919 | 216.52219405524 | 128.54828716224 |
1199 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2018 | 174.78522047304 | 228.68247830173001 | 135.76449190564 |
1200 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2019 | 178.68984082992 | 233.90111588050002 | 138.57806666488 |
1201 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 396 | Gonococcal infection | 3 | Rate | 2020 | 178.08318985718998 | 233.05102617129 | 137.61480046481 |
1202 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2005 | 481.77384757952 | 630.7700230576701 | 362.2392104219 |
1203 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2006 | 472.82737206926 | 620.00564407586 | 355.86075179148 |
1204 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2007 | 463.67771064331004 | 609.87997949018 | 350.05494967171 |
1205 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2008 | 455.09383845025997 | 600.57946158309 | 344.97214403874 |
1206 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2009 | 447.91379999546 | 593.25232352312 | 340.1700006028 |
1207 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2010 | 442.12453733915 | 587.83507185066 | 335.76075123174996 |
1208 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2011 | 442.51124008276 | 589.74467447294 | 336.57979502969 |
1209 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2012 | 449.71262998438 | 599.57472802793 | 341.29314464265997 |
1210 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2005 | 19.26113604516 | 20.400966483439998 | 18.20857435797 |
1211 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2006 | 19.21675807144 | 20.34542750613 | 18.1802353941 |
1212 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2007 | 19.16075156494 | 20.28847904013 | 18.10900261319 |
1213 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2008 | 19.09111656343 | 20.223060834250003 | 18.02588431349 |
1214 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2009 | 19.01442150599 | 20.15295944346 | 17.96584273349 |
1215 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2010 | 18.92244667099 | 20.0582078594 | 17.89394511033 |
1216 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2011 | 18.829641929359997 | 19.97975591633 | 17.7954818447 |
1217 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2012 | 18.72921308127 | 19.89357940639 | 17.688599664279998 |
1218 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2013 | 18.62753094056 | 19.79547044896 | 17.6034996669 |
1219 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2014 | 18.53420104055 | 19.71832626934 | 17.50763934769 |
1220 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2015 | 18.44389199332 | 19.65764487928 | 17.40746233991 |
1221 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2016 | 18.37362796596 | 19.59271627512 | 17.32858584624 |
1222 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2017 | 18.31246764113 | 19.51747997937 | 17.24746288131 |
1223 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2018 | 18.24864249723 | 19.46907452279 | 17.18704131992 |
1224 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2019 | 18.17227839408 | 19.408680440639998 | 17.10132907906 |
1225 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 615 | Sickle cell disorders | 3 | Rate | 2020 | 18.052480317599997 | 19.26458009565 | 16.96025995859 |
1226 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2013 | 459.45827440596 | 612.7750437573501 | 348.22162585566 |
1227 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2014 | 467.72319663177 | 623.67453176142 | 354.0365840738 |
1228 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2015 | 470.03342855315 | 626.92152973928 | 355.283498056 |
1229 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2016 | 472.14582137961 | 630.31450431775 | 356.29251006883 |
1230 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2017 | 478.95636598108996 | 640.06425716314 | 361.03829381339 |
1231 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2018 | 486.18127803268 | 653.07410831117 | 365.93277283584 |
1232 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2019 | 489.61089851089 | 661.47879335859 | 367.95430604340004 |
1233 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 395 | Chlamydial infection | 3 | Rate | 2020 | 490.29853839938 | 662.30721254903 | 367.92008452064005 |
1234 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2005 | 132.01693181038 | 136.32753860997 | 124.34956600350999 |
1235 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2006 | 131.43651235556 | 135.63164532642 | 123.28605540887999 |
1236 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2007 | 131.28076689875 | 135.51615663247 | 123.06050833954001 |
1237 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2008 | 132.11039612567 | 136.45368259335999 | 123.38145423478001 |
1238 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2009 | 134.78801202927 | 139.37161068812 | 125.59821357029999 |
1239 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2010 | 132.88929043245 | 137.51981300551998 | 123.68039432868001 |
1240 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2011 | 133.50508225998001 | 138.06151761311 | 124.18314482601 |
1241 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2012 | 132.91838832256 | 137.59188217375 | 123.57295044349999 |
1242 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2013 | 130.84178394839 | 135.69732881041 | 121.8192273859 |
1243 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2014 | 128.80074541477 | 133.51225539208 | 120.27998238981999 |
1244 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2015 | 124.29632690598 | 129.07826134213 | 115.75317129444 |
1245 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2016 | 122.02127644461 | 126.90410842482001 | 113.63369935848002 |
1246 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2017 | 118.73600180324999 | 123.33789437173 | 110.67964197824999 |
1247 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2018 | 115.26243395968 | 119.89908691666001 | 107.12457951988 |
1248 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2019 | 113.66411989653001 | 118.45952173085 | 105.76656072071 |
1249 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 426 | Tracheal, bronchus, and lung cancer | 3 | Rate | 2020 | 115.01175246051 | 119.77804883742002 | 106.63689169673 |
1250 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2005 | 8689.002101355189 | 11492.509699370949 | 6717.2466522062905 |
1251 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2006 | 8755.29830590996 | 11568.87777498737 | 6760.55738471991 |
1252 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2007 | 8806.35782618661 | 11646.351147616719 | 6795.818037569171 |
1253 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2008 | 8856.07767501996 | 11705.34011376077 | 6830.76321286091 |
1254 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2009 | 8911.2420582279 | 11775.75769869731 | 6869.00765504986 |
1255 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2010 | 8976.87532973124 | 11842.37180765742 | 6922.552380018859 |
1256 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2011 | 9076.472059734619 | 11916.61387323841 | 7006.40518943279 |
1257 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2012 | 9228.54599703834 | 12052.429250866011 | 7134.7541664932705 |
1258 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2013 | 9418.09764530187 | 12275.26813228565 | 7285.16974286995 |
1259 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2014 | 9632.68126220871 | 12576.55727656645 | 7432.08848262481 |
1260 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2015 | 9855.61928382009 | 12831.59921750395 | 7599.645744527191 |
1261 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2016 | 10174.335579335091 | 13230.616829280201 | 7831.41297088345 |
1262 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2017 | 10583.6277613158 | 13785.842004574239 | 8105.66642578342 |
1263 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2018 | 10932.26886681287 | 14285.93918924785 | 8337.15547356985 |
1264 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2019 | 11076.257175147219 | 14467.24749356697 | 8451.47760912246 |
1265 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 981 | Blindness and vision loss | 3 | Rate | 2020 | 9877.13264683104 | 12680.672038399249 | 7663.6393463454 |
1266 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2005 | 226.58614453641 | 264.31667888564 | 195.15483052560998 |
1267 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2006 | 230.74633757558 | 268.70988692942 | 198.93119035434 |
1268 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2007 | 238.1524296641 | 276.93654292546 | 205.49153578558003 |
1269 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2008 | 246.69863100768 | 286.46683784596 | 213.09632720138 |
1270 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2009 | 254.19451176642 | 294.67996349297 | 219.86303392553 |
1271 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2010 | 258.59751507757 | 299.18757503972 | 224.12259765854 |
1272 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2011 | 258.00083812882 | 298.07222812264996 | 224.14976187928 |
1273 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2012 | 253.78900216167 | 292.74333716487 | 221.08365208380002 |
1274 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2013 | 248.26473076451998 | 285.89979736854 | 216.69389553423 |
1275 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2014 | 243.67441596702997 | 280.14924163739 | 212.93137751591 |
1276 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2015 | 242.41233003856 | 278.16421169557 | 212.4710791542 |
1277 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2016 | 243.57510349555002 | 279.39406501889 | 213.78948433195998 |
1278 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2017 | 244.90633412923 | 280.85418457004 | 214.99235476602 |
1279 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2018 | 246.33915895789002 | 282.58955586858 | 216.26117315995003 |
1280 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2019 | 247.77016484937 | 283.9133015076 | 217.15559916174 |
1281 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 532 | Inflammatory bowel disease | 3 | Rate | 2020 | 248.90708286847 | 285.04926178588 | 218.01001849861 |
1282 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2005 | 135.47933570145 | 139.90593774354 | 127.56487713995 |
1283 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2006 | 139.67769150563998 | 144.27678001888 | 131.56485357588 |
1284 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2007 | 142.86403965349 | 147.51747805541 | 134.95693317283 |
1285 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2008 | 147.35516223042 | 152.23895813901999 | 139.22077107478 |
1286 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2009 | 153.52597184611 | 158.49118520783 | 145.01084466984 |
1287 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2010 | 162.25460650827 | 167.78904520219 | 152.51354446645 |
1288 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2011 | 169.47941842035002 | 175.18420680424 | 160.2917070698 |
1289 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2012 | 172.87307958026 | 179.03726089644002 | 162.93308723838 |
1290 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2013 | 178.77276964714002 | 185.08699482963 | 168.52405616325998 |
1291 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2014 | 185.70639011817 | 192.09376697486002 | 175.24915152283 |
1292 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2015 | 194.00801247075 | 200.89029735175 | 182.76338611345 |
1293 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2016 | 208.23972322338997 | 215.72915771104 | 195.87141529047 |
1294 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2017 | 213.91802810141002 | 221.69960295848998 | 201.24232186767003 |
1295 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2018 | 216.01567845501 | 224.48480667614 | 202.58496348604 |
1296 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2019 | 219.53968337584 | 228.42777599781 | 205.96862591643 |
1297 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 435 | Uterine cancer | 3 | Rate | 2020 | 221.11735483522 | 230.59795876887 | 206.85949862171998 |
1298 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2005 | 10113.58644791118 | 11116.02759877613 | 9159.33505586742 |
1299 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2006 | 10350.99468749405 | 11394.741821703281 | 9367.95493780309 |
1300 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2007 | 10680.08656133858 | 11743.252968254279 | 9659.76297078169 |
1301 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2008 | 11041.50330689002 | 12112.162785542061 | 10011.67022906704 |
1302 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2009 | 11367.354873778431 | 12462.902392681239 | 10328.27432883351 |
1303 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2010 | 11626.010026320451 | 12763.41234606053 | 10560.96945192268 |
1304 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2011 | 11806.29794365458 | 12963.397458145258 | 10724.966902012171 |
1305 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2012 | 11987.04530803844 | 13168.20808700214 | 10885.347420338649 |
1306 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2013 | 12166.70544498359 | 13357.14078098213 | 11045.11070438413 |
1307 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2014 | 12338.8086747092 | 13537.43515326958 | 11196.54830430003 |
1308 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2015 | 12530.54228753546 | 13744.95147298386 | 11363.27720812916 |
1309 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2016 | 12748.212214990459 | 14005.39632154296 | 11541.872065374071 |
1310 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2017 | 13023.380482252838 | 14326.336240192011 | 11772.81809555682 |
1311 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2018 | 13333.98539765323 | 14691.36188065979 | 12054.83434305266 |
1312 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2019 | 13652.36897057075 | 15066.281621746499 | 12291.84842813107 |
1313 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 628 | Osteoarthritis | 3 | Rate | 2020 | 14127.08448207112 | 15609.6355283818 | 12622.27849188792 |
1314 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2005 | 8.99318819973 | 9.21918577508 | 8.65910518481 |
1315 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2006 | 9.3874644501 | 9.6184839165 | 9.03779901571 |
1316 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2007 | 9.92106183296 | 10.167854373019999 | 9.54128108821 |
1317 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2008 | 10.45389030514 | 10.720468194330001 | 10.03476323198 |
1318 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2009 | 10.94854357973 | 11.23534967145 | 10.48119933071 |
1319 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2010 | 11.37540906214 | 11.680736377550001 | 10.87406652875 |
1320 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2011 | 11.72002549893 | 12.03226719365 | 11.19383883479 |
1321 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2012 | 12.01802429412 | 12.33522314288 | 11.463044972510001 |
1322 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2013 | 12.32101647218 | 12.6562032094 | 11.75028154666 |
1323 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2014 | 12.596145557929999 | 12.930686243950001 | 12.01100625718 |
1324 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2015 | 12.882685621050001 | 13.233838389530002 | 12.27792721998 |
1325 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2016 | 13.16186241641 | 13.51575416618 | 12.54479052177 |
1326 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2017 | 13.38828938295 | 13.7549809635 | 12.74411083151 |
1327 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2018 | 13.638439913749998 | 14.01528147471 | 12.95051651007 |
1328 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2019 | 13.883066279100001 | 14.302382378690002 | 13.14784738034 |
1329 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 417 | Liver cancer | 3 | Rate | 2020 | 14.06068029711 | 14.52280404927 | 13.227293404340001 |
1330 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2005 | 109.90550587402001 | 117.29846330477999 | 102.34354486955 |
1331 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2006 | 109.8618167848 | 116.97668402557 | 102.53478920581 |
1332 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2007 | 109.97110220595 | 117.20215119399 | 102.9060104587 |
1333 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2008 | 110.04907818836 | 117.39585548123999 | 102.95175782748 |
1334 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2009 | 109.97537903442999 | 117.07487205594 | 102.8966732089 |
1335 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2010 | 109.60372094549001 | 116.84323413234999 | 102.25222395264 |
1336 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2011 | 108.88692717175 | 115.77594988347 | 101.87261489164 |
1337 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2012 | 107.88792905925 | 114.70723951395 | 100.83992960388 |
1338 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2013 | 106.79735316784999 | 113.4492264866 | 99.72084436092 |
1339 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2014 | 105.8106960258 | 112.33210482307001 | 98.77324554362 |
1340 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2015 | 105.03986499111 | 111.54639115846 | 97.99551687509 |
1341 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2016 | 104.18468271767001 | 110.57278639527001 | 97.60360840874 |
1342 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2017 | 102.99580031001 | 109.37424853601999 | 96.78395932994 |
1343 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2018 | 101.78252609284 | 107.95201977225001 | 95.43508610978 |
1344 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2019 | 100.84668232845 | 107.20040126654001 | 94.55764584518 |
1345 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 400 | Acute hepatitis | 3 | Rate | 2020 | 100.13777537559001 | 106.28195449462999 | 93.61367729164999 |
1346 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2005 | 148.33068028726998 | 160.67415247389 | 135.81421404826 |
1347 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2006 | 150.53315012862 | 162.96644178442 | 138.06773604691 |
1348 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2007 | 153.11384931721 | 165.69256699171999 | 140.54421155527 |
1349 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2008 | 156.13788916203 | 168.98301835498 | 143.34258265782 |
1350 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2009 | 158.8564937035 | 172.08081620261 | 145.86295601402 |
1351 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2010 | 161.9206078028 | 175.29145304109 | 148.71525419566 |
1352 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2011 | 164.70982855238998 | 178.28601783778998 | 151.36493037474 |
1353 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2012 | 168.0593874679 | 181.97653423146 | 154.46234437631 |
1354 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2013 | 171.89499840143 | 185.98938042048 | 157.82926694704 |
1355 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2014 | 175.38650829044 | 189.78006425676 | 160.88037625601999 |
1356 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2015 | 179.32159391125 | 194.17080785234 | 164.35994540913 |
1357 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2016 | 183.15695634653 | 198.31797622974 | 167.82101946122 |
1358 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2017 | 188.12148811262 | 203.86310849933002 | 172.66898500656998 |
1359 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2018 | 193.69750555512 | 210.01600826662997 | 177.98222774717001 |
1360 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2019 | 198.87866369215 | 215.74209112902003 | 182.8536389231 |
1361 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 544 | Parkinson's disease | 3 | Rate | 2020 | 203.91708683865002 | 221.63641247393 | 187.28533706443 |
1362 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2005 | 882.58937117201 | 917.1330715248799 | 838.32659043934 |
1363 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2006 | 877.7735353344101 | 913.8466803122899 | 834.71886699693 |
1364 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2007 | 873.51028943856 | 909.7435451272 | 828.8372357829701 |
1365 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2008 | 878.11078119597 | 914.42962380264 | 832.19097162666 |
1366 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2009 | 890.1711939177 | 926.46127200666 | 842.9712746757301 |
1367 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2010 | 889.3640860757199 | 927.9726064392 | 843.07181686536 |
1368 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2011 | 890.98953000721 | 929.74428048264 | 844.4796490593201 |
1369 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2012 | 885.8442027347501 | 925.36261525531 | 840.19304207227 |
1370 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2013 | 877.7163623777701 | 915.38903023414 | 832.99657444014 |
1371 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2014 | 876.7590576271 | 914.52352924579 | 830.5090416776001 |
1372 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2015 | 879.43032284766 | 917.8567869291 | 833.8116250564199 |
1373 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2016 | 886.0194161679401 | 926.8532391449401 | 838.9682544532999 |
1374 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2017 | 884.58528711818 | 926.8347975612301 | 834.74716168609 |
1375 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2018 | 880.6105016373 | 924.45383986019 | 828.63489763845 |
1376 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2019 | 881.43245807236 | 927.50221207478 | 828.4702924531401 |
1377 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 429 | Breast cancer | 3 | Rate | 2020 | 886.8581933402901 | 933.67719959759 | 834.41024361573 |
1378 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2005 | 33.4590132665 | 40.00444577415 | 28.18651023549 |
1379 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2006 | 32.84065245715 | 38.72549829868 | 28.045579353110003 |
1380 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2007 | 32.1043184431 | 37.2548963539 | 27.81424542397 |
1381 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2008 | 31.3475541545 | 35.837919838590004 | 27.339399519609998 |
1382 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2009 | 30.684586840909997 | 34.76634732178 | 26.859648427480003 |
1383 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2010 | 30.21609667787 | 34.17901635418 | 26.528359802470003 |
1384 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2011 | 29.90707589129 | 33.69564027368 | 26.40085041088 |
1385 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2012 | 29.61996558923 | 33.22791024613 | 26.211087134990002 |
1386 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2013 | 29.373130028909998 | 32.76836863313 | 26.06508425565 |
1387 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2014 | 29.186980629239997 | 32.48359002462 | 26.05003259227 |
1388 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2015 | 29.06854104551 | 32.32414291093 | 26.10295630781 |
1389 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2016 | 29.42034673002 | 32.76591708795 | 26.430221746789996 |
1390 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2017 | 30.31713645814 | 34.08506078597 | 27.199202408989997 |
1391 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2018 | 31.329913505599997 | 35.45348325448 | 27.977352862950003 |
1392 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2019 | 32.03704851023 | 36.24438025507 | 28.428528373419997 |
1393 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 645 | Down syndrome | 3 | Rate | 2020 | 32.3374108149 | 36.80319464504 | 28.31101760649 |
1394 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2005 | 637.93766752038 | 659.33015656953 | 609.1948921294099 |
1395 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2006 | 640.16786627814 | 660.98897462379 | 610.06460044441 |
1396 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2007 | 648.36733150451 | 669.56636467901 | 617.50329677034 |
1397 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2008 | 658.07800368004 | 679.99411187175 | 627.0448708065001 |
1398 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2009 | 669.47574131445 | 691.61187970625 | 637.7770142015601 |
1399 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2010 | 686.76770602297 | 708.59978383007 | 654.35949735385 |
1400 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2011 | 684.43179644518 | 705.97869075833 | 653.2969611062 |
1401 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2012 | 684.3580550396 | 706.22433072051 | 653.74238338757 |
1402 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2013 | 688.03824749699 | 710.64868345513 | 657.1127355716401 |
1403 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2014 | 699.45254341909 | 722.36337828323 | 666.73719910719 |
1404 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2015 | 714.42934604918 | 737.7825996964 | 680.27468919302 |
1405 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2016 | 741.31857438656 | 767.73725937381 | 706.77644918196 |
1406 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2017 | 748.5892096977001 | 776.4998258358 | 711.87446727269 |
1407 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2018 | 759.4325011902 | 788.90045126005 | 722.43772421373 |
1408 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2019 | 770.1376402997801 | 800.5654175929701 | 731.9740850458099 |
1409 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 438 | Prostate cancer | 3 | Rate | 2020 | 783.1124071482 | 815.26140078016 | 743.5232998545199 |
1410 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2005 | 35.32077154407 | 36.18476333129 | 33.70399315698 |
1411 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2006 | 35.00007997317 | 35.82556008649 | 33.370333177 |
1412 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2007 | 34.06082986341 | 34.86707758141 | 32.51100398889 |
1413 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2008 | 33.72284635819 | 34.54126150687 | 32.17710237921 |
1414 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2009 | 34.06977211413 | 34.86818736363 | 32.467306206850004 |
1415 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2010 | 32.82529098568 | 33.7243841619 | 31.278191964119998 |
1416 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2011 | 32.58552857585 | 33.40863695124 | 31.035297383570004 |
1417 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2012 | 32.20138695094 | 33.082941568100004 | 30.544710564640003 |
1418 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2013 | 31.536362212180002 | 32.35106247176 | 29.953392903 |
1419 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2014 | 31.48726373739 | 32.31707069931 | 29.97866293806 |
1420 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2015 | 30.45445636423 | 31.31382369845 | 29.00828750069 |
1421 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2016 | 30.79140706778 | 31.63184907109 | 29.293443345529997 |
1422 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2017 | 30.28696093946 | 31.15055031053 | 28.79316384358 |
1423 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2018 | 29.58452845854 | 30.47279744929 | 28.02623995052 |
1424 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2019 | 28.71549918734 | 29.683356362940003 | 27.227967102690002 |
1425 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 465 | Ovarian cancer | 3 | Rate | 2020 | 28.65555654884 | 29.70331448188 | 27.094916964470002 |
1426 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2005 | 1067.6418044775799 | 1082.02276403199 | 1053.48408296646 |
1427 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2006 | 1070.74216190595 | 1085.91516189575 | 1055.78143197916 |
1428 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2007 | 1074.15742496005 | 1090.3616732556 | 1058.0989589957999 |
1429 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2008 | 1078.47599560343 | 1095.59768807129 | 1061.18358608766 |
1430 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2009 | 1083.9842300539 | 1102.53655103623 | 1065.5539502291 |
1431 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2010 | 1091.23507642801 | 1111.0131178778 | 1071.4900571809 |
1432 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2011 | 1099.1299979401201 | 1119.30233136718 | 1079.34727760047 |
1433 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2012 | 1107.24899711339 | 1127.81984989809 | 1087.38098344669 |
1434 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2013 | 1115.30043594438 | 1136.17878651525 | 1095.2883686251 |
1435 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2014 | 1123.19860983416 | 1144.30172128953 | 1103.35681885738 |
1436 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2015 | 1131.18845966337 | 1152.64264014464 | 1110.53025305312 |
1437 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2016 | 1139.49603951097 | 1160.57596583202 | 1118.9312788288 |
1438 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2017 | 1148.22884501054 | 1169.46015599918 | 1127.75978537591 |
1439 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2018 | 1156.61904443133 | 1178.0540099633301 | 1136.28248586224 |
1440 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2019 | 1164.16548390534 | 1185.8259597005099 | 1143.59358393705 |
1441 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 655 | Psoriasis | 3 | Rate | 2020 | 1170.31879480985 | 1191.51832500716 | 1148.76463495803 |
1442 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2005 | 243.58517442885 | 249.03105616088 | 234.36228750979 |
1443 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2006 | 243.5059639331 | 249.200160488 | 234.21833726417 |
1444 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2007 | 243.66180205823 | 249.54641526721 | 234.43564542836 |
1445 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2008 | 247.80494014108 | 253.99922626818 | 238.03267656645 |
1446 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2009 | 259.55007991727 | 265.75418029434 | 249.16770529933 |
1447 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2010 | 258.90824281069 | 265.12296217333 | 248.0618900415 |
1448 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2011 | 256.38123040886 | 262.62545093176 | 245.54841734111997 |
1449 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2012 | 252.85946453924 | 259.24097170145 | 241.86675573677 |
1450 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2013 | 248.77154273618 | 255.27131993817 | 237.81108768719 |
1451 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2014 | 241.58741995373 | 248.14084463397 | 230.67467681741 |
1452 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2015 | 230.3940240708 | 236.54360283429 | 219.54221838326 |
1453 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2016 | 220.448839876 | 226.33169129955 | 210.20860210682997 |
1454 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2017 | 213.53293933445 | 219.24867918868 | 203.35680975435997 |
1455 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2018 | 209.43139489412 | 215.52769554852 | 199.14669478576 |
1456 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2019 | 207.28268157208 | 213.50065566608 | 197.24081746616 |
1457 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 459 | Malignant skin melanoma | 3 | Rate | 2020 | 208.55045542694 | 215.16110662302 | 197.89043026166 |
1458 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2005 | 70.05134573952 | 72.21100446166 | 66.34107560352 |
1459 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2006 | 70.48785496769 | 72.67410328151 | 66.60687823813 |
1460 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2007 | 70.14983832217 | 72.35110384712 | 66.36156550044 |
1461 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2008 | 70.59246686179 | 72.77310933929 | 66.77009755869 |
1462 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2009 | 72.16762334517999 | 74.44765211995 | 68.23563077631 |
1463 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2010 | 71.40520028995 | 73.82565585661 | 67.46188383184 |
1464 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2011 | 70.76885627342 | 73.11029506023 | 66.6525587198 |
1465 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2012 | 69.95490634617 | 72.30408077385 | 65.95710561849 |
1466 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2013 | 67.98897044374 | 70.30557359872 | 64.04242289515 |
1467 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2014 | 64.49460536273 | 66.86907635218 | 60.67008628444 |
1468 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2015 | 60.88717627458 | 63.059103469549996 | 57.309478330059996 |
1469 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2016 | 60.17629877471 | 62.28043524687 | 56.53934223338 |
1470 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2017 | 58.62618407888 | 60.78026951282 | 54.911009821440004 |
1471 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2018 | 57.23497399467001 | 59.466986113519994 | 53.54049723025 |
1472 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2019 | 56.87792203057 | 59.155797368040005 | 53.156742005729996 |
1473 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 487 | Leukemia | 3 | Rate | 2020 | 57.049573602959995 | 59.38651187581 | 53.23189866606 |
1474 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2005 | 54.52625484363 | 55.683940788689995 | 53.094800430949995 |
1475 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2006 | 54.08795597106 | 55.35250550297 | 52.72974941525 |
1476 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2007 | 53.82631756796 | 55.142513859420006 | 52.39159647876 |
1477 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2008 | 53.43637371353 | 54.71747132198001 | 51.905045618719996 |
1478 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2009 | 54.224265488069996 | 55.38170052694 | 52.75928693408999 |
1479 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2010 | 54.01946814364 | 55.28112563826 | 52.541392186820005 |
1480 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2011 | 54.54638890462999 | 55.78255802372001 | 53.04846216919 |
1481 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2012 | 55.0465779685 | 56.34832674768 | 53.51936692276 |
1482 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2013 | 55.585161400800004 | 56.80970524409 | 54.013675923620006 |
1483 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2014 | 55.338381000160005 | 56.664303650149996 | 53.89488318134 |
1484 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2015 | 55.67726095852 | 56.89998329646 | 54.37763357386 |
1485 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2016 | 55.74866693935 | 57.05276096883 | 54.363095301600005 |
1486 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2017 | 54.91856202606 | 56.17379837974 | 53.48814858466999 |
1487 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2018 | 52.74165522248 | 54.066674135839996 | 51.19329090064 |
1488 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2019 | 51.77685157938 | 53.10347038221 | 50.26407065505 |
1489 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 432 | Cervical cancer | 3 | Rate | 2020 | 51.15335567418 | 52.837749888759994 | 49.415095522330006 |
1490 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2005 | 652.77875196121 | 692.4380735780301 | 618.22245377695 |
1491 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2006 | 653.65598613896 | 693.37861011877 | 619.7768987981 |
1492 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2007 | 654.2038192722 | 693.42469278599 | 620.82183282202 |
1493 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2008 | 654.5614961941201 | 693.2461264739501 | 621.91308460107 |
1494 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2009 | 655.08816205739 | 693.61188935381 | 622.11702141489 |
1495 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2010 | 655.53901206846 | 693.91674215393 | 622.4044429885 |
1496 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2011 | 656.03515888901 | 694.25845454747 | 623.0840834961 |
1497 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2012 | 656.32684367868 | 694.4399002126199 | 623.62362271224 |
1498 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2013 | 656.46095169955 | 694.53079341877 | 624.15997878143 |
1499 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2014 | 656.70440641492 | 694.81037967109 | 624.65713783925 |
1500 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2015 | 656.85959721825 | 694.9813577758899 | 624.8226108881299 |
1501 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2016 | 657.17970136065 | 695.23244785813 | 625.49251103892 |
1502 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2017 | 657.44291407528 | 695.58316470921 | 626.30766703514 |
1503 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2018 | 657.68899684087 | 695.97659611118 | 625.97841257625 |
1504 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2019 | 658.05667780443 | 696.46795409788 | 626.13736361651 |
1505 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 570 | Bipolar disorder | 3 | Rate | 2020 | 658.4301552220101 | 696.67679044226 | 626.74287591387 |
1506 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2005 | 1.31953934056 | 1.6360900572800001 | 1.0786127627 |
1507 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2006 | 1.30287983227 | 1.6183787801299998 | 1.07002289767 |
1508 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2007 | 1.28135263359 | 1.57508162536 | 1.05745261858 |
1509 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2008 | 1.25570845088 | 1.5341299222399998 | 1.04075106146 |
1510 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2009 | 1.2287736495 | 1.49471225867 | 1.02151841463 |
1511 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2010 | 1.20349936097 | 1.45837220773 | 1.00504189844 |
1512 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2011 | 1.1805064492500001 | 1.4223610196899998 | 0.99234065852 |
1513 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2012 | 1.15787860958 | 1.38900977866 | 0.9766891785399999 |
1514 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2013 | 1.13648654609 | 1.36047532376 | 0.9592764846699999 |
1515 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2014 | 1.11712711298 | 1.33739591039 | 0.94491535253 |
1516 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2015 | 1.09955471526 | 1.3050991215999999 | 0.92823351229 |
1517 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2016 | 1.08267883494 | 1.28482293794 | 0.92047926621 |
1518 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2017 | 1.0657348546499998 | 1.25945291001 | 0.91132941744 |
1519 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2018 | 1.05031877732 | 1.24419044587 | 0.8967859106299999 |
1520 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2019 | 1.0378221197600002 | 1.23121218015 | 0.8885277454599999 |
1521 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 614 | Thalassemias | 3 | Rate | 2020 | 1.02912893896 | 1.22222671058 | 0.8784318245899999 |
1522 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2005 | 142.93638873576 | 150.1434699774 | 134.85129609383 |
1523 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2006 | 140.51500253063 | 147.70561671714 | 132.71326109295 |
1524 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2007 | 140.25767709419 | 147.3692904801 | 132.43573944471999 |
1525 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2008 | 141.13467455161 | 148.35948223214 | 133.48448267349 |
1526 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2009 | 143.98497130127 | 151.01791945566998 | 136.57030067747 |
1527 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2010 | 144.20184572301 | 151.3548059565 | 136.49316328626 |
1528 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2011 | 143.67854816125 | 150.88154007740002 | 135.92789085345 |
1529 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2012 | 140.9340769809 | 148.09874478629 | 133.16123906632 |
1530 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2013 | 138.21586652368998 | 145.27902228207 | 130.51511319237002 |
1531 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2014 | 137.06083044411 | 144.09377135071 | 129.08282329391 |
1532 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2015 | 136.14699179157 | 143.55153300021 | 127.97456297048 |
1533 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2016 | 136.72117759047 | 144.24361254711 | 128.26052120196002 |
1534 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2017 | 135.49619461622 | 143.15024905241998 | 126.80621693186 |
1535 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2018 | 132.89141932673 | 140.49849238673 | 124.19468021443001 |
1536 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2019 | 132.06374175836999 | 139.73680984005 | 123.34461823943 |
1537 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 485 | Non-Hodgkin lymphoma | 3 | Rate | 2020 | 133.5443175682 | 141.25095539052 | 124.39271360949999 |
1538 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2005 | 362.23390838002 | 375.36157787549 | 342.08167704042 |
1539 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2006 | 362.90510316769996 | 375.89099551037003 | 342.93476738375 |
1540 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2007 | 365.05603598928997 | 378.00100887598 | 345.51663011671 |
1541 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2008 | 368.72376623719 | 381.37859689367 | 348.22449677529 |
1542 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2009 | 372.95354855018 | 386.53268797682 | 352.23022857934 |
1543 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2010 | 375.07201220252 | 388.88928185281003 | 353.86232110348004 |
1544 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2011 | 377.82486186889 | 391.7523137205 | 356.6645044013 |
1545 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2012 | 376.78529140025 | 390.70187542686 | 354.65762054565 |
1546 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2013 | 375.64550252476 | 389.78205521504 | 353.62377362224004 |
1547 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2014 | 375.44605323027 | 389.21547664691997 | 353.54871842052 |
1548 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2015 | 379.81085998359 | 393.27354472618003 | 356.92161848803 |
1549 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2016 | 385.6835008582 | 399.72737135781 | 362.14920108544 |
1550 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2017 | 385.34621486602 | 399.94104448198 | 361.75936474974 |
1551 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2018 | 381.94792116572 | 396.54306404819 | 358.49160951751 |
1552 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2019 | 382.3478519053 | 397.08127495483 | 358.83010083036 |
1553 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 441 | Colon and rectum cancer | 3 | Rate | 2020 | 385.63001574463 | 400.87133718273003 | 361.34692034759 |
1554 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2005 | 1062.15233546499 | 1250.7326058966498 | 890.3564390024601 |
1555 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2006 | 1061.14942237177 | 1249.31272886332 | 889.1491393131499 |
1556 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2007 | 1059.5589010548001 | 1247.26690937998 | 887.47908277015 |
1557 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2008 | 1057.67537087364 | 1245.6527631982901 | 885.28198133016 |
1558 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2009 | 1056.00524814565 | 1245.7992104365399 | 883.6440795208299 |
1559 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2010 | 1054.62896319832 | 1246.36026207315 | 882.45284822212 |
1560 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2011 | 1054.2299228003199 | 1245.3748531367798 | 882.6150444297199 |
1561 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2012 | 1054.4716386237499 | 1245.1352947072799 | 883.28750532192 |
1562 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2013 | 1054.88598455798 | 1244.96131050319 | 884.3624132977301 |
1563 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2014 | 1055.20224858143 | 1244.5110377946498 | 885.33144453914 |
1564 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2015 | 1054.6655249632 | 1243.09311607225 | 885.57303315886 |
1565 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2016 | 1053.62821817583 | 1242.51364432086 | 884.0134012498199 |
1566 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2017 | 1052.27295053653 | 1241.70468180423 | 882.0576617517701 |
1567 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2018 | 1050.7310834729901 | 1240.70944728633 | 880.49996811243 |
1568 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2019 | 1049.25618085421 | 1239.74556221466 | 879.11674330746 |
1569 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 575 | Autism spectrum disorders | 3 | Rate | 2020 | 1048.67761758944 | 1233.20922348831 | 873.6325433113401 |
1570 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2005 | 18640.528799008902 | 19683.39520703916 | 17628.85397398247 |
1571 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2006 | 18723.46731689249 | 19766.944201257742 | 17711.63099034501 |
1572 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2007 | 18774.46949608854 | 19836.13260582271 | 17749.714927294448 |
1573 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2008 | 18829.54734522809 | 19911.0891409993 | 17790.11055660981 |
1574 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2009 | 18900.59595283576 | 20011.8326724033 | 17859.73437018125 |
1575 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2010 | 19076.37428388248 | 20203.92276890334 | 18011.206699906503 |
1576 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2011 | 19280.821073644518 | 20418.8852075064 | 18219.31675468132 |
1577 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2012 | 19503.67433803076 | 20677.00383595711 | 18441.09821896638 |
1578 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2013 | 19738.36055037671 | 20927.81123979082 | 18662.25869808409 |
1579 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2014 | 19963.06331252984 | 21164.69631357979 | 18857.41108868398 |
1580 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2015 | 20228.66713433617 | 21459.51837897163 | 19116.17206531183 |
1581 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2016 | 20502.13542443166 | 21775.48004723635 | 19376.58314094739 |
1582 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2017 | 20817.98889005358 | 22142.40409118283 | 19681.098640389668 |
1583 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2018 | 21147.38110527843 | 22489.74674646487 | 20008.75999214375 |
1584 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2019 | 21452.3493567176 | 22835.381636143058 | 20288.161502980838 |
1585 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 674 | Age-related and other hearing loss | 3 | Rate | 2020 | 21739.21009141911 | 23115.57141820024 | 20550.872223855542 |
1586 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2005 | 347.8108623366 | 379.99396827266 | 322.25936321877 |
1587 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2006 | 353.84254232002 | 386.70150021246997 | 327.67129643499 |
1588 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2007 | 360.33409199148 | 393.80290684935994 | 333.39207999541003 |
1589 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2008 | 366.9793132592 | 400.68062203399 | 339.21160689253 |
1590 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2009 | 373.28732893215005 | 407.1643818026 | 344.70562887547 |
1591 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2010 | 379.50313325339 | 413.51624324126 | 350.08915704456 |
1592 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2011 | 385.23730292999 | 420.17368514408 | 355.11732156317 |
1593 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2012 | 391.33029851915 | 427.02864655481 | 360.5366921308 |
1594 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2013 | 397.361286183 | 433.91399245139 | 366.28621716862 |
1595 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2014 | 403.00086368628 | 440.42421818719004 | 371.82662958417 |
1596 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2015 | 408.55477705250996 | 446.11158503038 | 377.29850594389 |
1597 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2016 | 413.59514287727 | 451.68451312101 | 382.04408860131 |
1598 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2017 | 418.67707364314 | 457.72359923352 | 386.38586461918 |
1599 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2018 | 423.68721492149 | 463.32841613411995 | 390.85962523455 |
1600 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2019 | 428.64067405281 | 469.33957874424 | 395.37281985217 |
1601 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 627 | Rheumatoid arthritis | 3 | Rate | 2020 | 434.20767478503 | 474.04641102876 | 400.15217871177003 |
1602 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2005 | 9444.261865054441 | 10034.26814824426 | 8829.03805005706 |
1603 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2006 | 9538.80271909911 | 10141.85916037667 | 8917.92164279178 |
1604 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2007 | 9708.90072100173 | 10325.50320161328 | 9073.474683126791 |
1605 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2008 | 9916.46629826306 | 10548.940032679791 | 9259.65864588673 |
1606 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2009 | 10103.70892417944 | 10759.58597264249 | 9426.35740338661 |
1607 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2010 | 10256.53874956074 | 10929.7912367198 | 9568.59830764302 |
1608 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2011 | 10362.93767959205 | 11042.83736679359 | 9664.400158789831 |
1609 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2012 | 10484.75969073456 | 11168.50761770192 | 9769.65103403558 |
1610 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2013 | 10624.08624522852 | 11314.09479888654 | 9890.804460069801 |
1611 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2014 | 10760.34941582761 | 11464.84116391969 | 10009.66510073333 |
1612 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2015 | 10920.60230927215 | 11630.41817470114 | 10150.11988531323 |
1613 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2016 | 11088.924402497729 | 11807.01359503637 | 10289.833369794831 |
1614 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2017 | 11289.67092810521 | 12028.62529960513 | 10463.356062567671 |
1615 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2018 | 11492.2246548743 | 12250.20862370973 | 10640.10666655368 |
1616 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2019 | 11648.81280616876 | 12417.32826809815 | 10790.06400500462 |
1617 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 589 | Chronic kidney disease | 3 | Rate | 2020 | 11516.34187702527 | 12249.721980920649 | 10681.6290559843 |
1618 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2005 | 12.751674815129999 | 13.19029386451 | 11.97862457304 |
1619 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2006 | 12.914779255940001 | 13.37231916485 | 12.111061438610001 |
1620 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2007 | 13.101790819760001 | 13.56251988521 | 12.27993128949 |
1621 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2008 | 13.36302797826 | 13.849441055289999 | 12.48433269933 |
1622 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2009 | 13.65358021581 | 14.12375326968 | 12.763582111499998 |
1623 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2010 | 13.89100050191 | 14.39303849819 | 12.96688678321 |
1624 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2011 | 14.116926020829998 | 14.6439793621 | 13.15557426504 |
1625 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2012 | 14.36264108642 | 14.88816201968 | 13.377244016799999 |
1626 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2013 | 14.43931699688 | 14.97889453666 | 13.424137791539998 |
1627 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2014 | 14.692065582369999 | 15.24893875271 | 13.6762346457 |
1628 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2015 | 14.95776648974 | 15.519721108679999 | 13.92193260352 |
1629 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2016 | 15.33301662035 | 15.9135353985 | 14.270343442769999 |
1630 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2017 | 15.503389214370001 | 16.10859336911 | 14.44290068448 |
1631 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2018 | 15.56870996532 | 16.18175102849 | 14.48507565772 |
1632 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2019 | 15.80111820223 | 16.45309875592 | 14.69879702385 |
1633 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 456 | Pancreatic cancer | 3 | Rate | 2020 | 15.94533193525 | 16.59272166506 | 14.772708589299999 |
1634 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2005 | 473.82389683776995 | 550.9369442810299 | 415.18073850451003 |
1635 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2006 | 481.66878384425 | 558.84089334927 | 422.83937292436 |
1636 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2007 | 490.12543320526 | 568.6399187040801 | 430.61730970772004 |
1637 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2008 | 499.2608323868 | 580.66063404633 | 438.47078362742997 |
1638 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2009 | 507.34160668496 | 589.4157976605101 | 445.70898688907 |
1639 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2010 | 516.3594325192 | 597.6846620023 | 453.69363834668 |
1640 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2011 | 524.55347497629 | 606.91567128706 | 461.08669141018004 |
1641 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2012 | 534.54935978638 | 619.25558434747 | 469.86799906675003 |
1642 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2013 | 545.43761626183 | 632.82806152871 | 479.55108818101996 |
1643 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2014 | 555.3499288372 | 645.35705832698 | 488.48236155143996 |
1644 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2015 | 566.4465517385 | 659.21487619298 | 498.51135368843 |
1645 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2016 | 576.78360813014 | 672.49665387542 | 506.96464670446 |
1646 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2017 | 588.96095284404 | 687.46560852738 | 516.8366980086699 |
1647 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2018 | 602.20733544843 | 703.8236147415 | 527.75432868021 |
1648 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2019 | 614.82593697413 | 719.4119632931901 | 538.76414188962 |
1649 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 462 | Non-melanoma skin cancer | 3 | Rate | 2020 | 627.45587076915 | 734.35564613228 | 549.57618812868 |
1650 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2005 | 7157.753076876889 | 8114.21973121268 | 6338.16187289914 |
1651 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2006 | 7364.808498298151 | 8270.55453053069 | 6565.00717508888 |
1652 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2007 | 7774.11974736692 | 8671.90106323878 | 6994.02175983275 |
1653 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2008 | 8269.23643004205 | 9159.5870038574 | 7508.823267655421 |
1654 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2009 | 8730.15469583054 | 9619.317433204309 | 7986.21076627586 |
1655 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2010 | 9036.761439762531 | 9922.22088706668 | 8322.58933600662 |
1656 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2011 | 9217.68582781904 | 10101.71783042001 | 8516.66684009426 |
1657 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2012 | 9383.47979409644 | 10267.21327104662 | 8689.15092250423 |
1658 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2013 | 9527.63531930879 | 10404.07443450868 | 8829.48600740318 |
1659 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2014 | 9642.0182874693 | 10495.398303100039 | 8945.7975882687 |
1660 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2015 | 9722.101375286 | 10575.08916732366 | 9034.31147404203 |
1661 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2016 | 9783.10699482267 | 10644.140214290861 | 9049.6749875113 |
1662 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2017 | 9847.99285907042 | 10739.670083973971 | 9091.39278346717 |
1663 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2018 | 9910.40675747193 | 10843.987375819821 | 9122.61460813225 |
1664 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2019 | 9966.267824128081 | 10953.205927017689 | 9129.30181117631 |
1665 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 515 | Asthma | 3 | Rate | 2020 | 10016.05726622047 | 11097.14422193887 | 9098.58296873508 |
1666 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2005 | 12577.69771793825 | 13582.82691977947 | 11582.2419825894 |
1667 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2006 | 12714.091187932381 | 13734.803622729449 | 11719.2590212297 |
1668 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2007 | 12847.795800223392 | 13866.51469569081 | 11841.37164564666 |
1669 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2008 | 12989.00984623652 | 14022.041584247441 | 11970.14569629912 |
1670 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2009 | 13137.57724749716 | 14186.65929929234 | 12087.701123694209 |
1671 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2010 | 13309.908038587651 | 14392.89843397582 | 12223.642872804321 |
1672 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2011 | 13515.41684734518 | 14617.79047287351 | 12401.27792067121 |
1673 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2012 | 13761.14960491765 | 14879.968194336449 | 12611.70102370562 |
1674 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2013 | 14015.24953596883 | 15165.90300483866 | 12835.22075901012 |
1675 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2014 | 14239.415016454921 | 15410.92122123728 | 13031.480206485341 |
1676 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2015 | 14410.628528439509 | 15619.40811870414 | 13180.679417205622 |
1677 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2016 | 14530.4745549958 | 15761.767611358498 | 13302.97418235811 |
1678 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2017 | 14647.186993362971 | 15890.17257414532 | 13422.10015693498 |
1679 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2018 | 14763.23483789698 | 16016.070188720541 | 13513.77788634375 |
1680 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2019 | 14878.58867297221 | 16158.16864344157 | 13609.172290331839 |
1681 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 521 | Cirrhosis and other chronic liver diseases | 3 | Rate | 2020 | 14970.86005432076 | 16225.3143197169 | 13733.98315387253 |
1682 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2005 | 23.959609291670002 | 24.62644435763 | 23.34754971693 |
1683 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2006 | 24.181449225959998 | 24.840624306189998 | 23.6170159672 |
1684 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2007 | 23.50727233411 | 24.143470506499998 | 22.96013030268 |
1685 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2008 | 22.7602875298 | 23.36504276118 | 22.226491225 |
1686 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2009 | 23.52499639872 | 24.11797931812 | 22.974825296669998 |
1687 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2010 | 22.955515042629997 | 23.5552465998 | 22.37978031977 |
1688 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2011 | 21.74266146502 | 22.306507130900002 | 21.20374820245 |
1689 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2012 | 20.39627599476 | 20.91175242433 | 19.83832703547 |
1690 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2013 | 19.34127784364 | 19.836786037619998 | 18.82756635064 |
1691 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2014 | 18.625234473880003 | 19.10890034941 | 18.08548353877 |
1692 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2015 | 17.79826509573 | 18.256759920100002 | 17.242724839370002 |
1693 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2016 | 16.55770640219 | 17.00584356072 | 16.07483348181 |
1694 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2017 | 16.02887710749 | 16.4713865959 | 15.52745409468 |
1695 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2018 | 15.453860399509999 | 15.92320810437 | 14.904875491239999 |
1696 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2019 | 14.755757977030001 | 15.2317682222 | 14.20832466922 |
1697 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 484 | Hodgkin lymphoma | 3 | Rate | 2020 | 14.641302656689998 | 15.173659098369999 | 14.04355858292 |
1698 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2005 | 1203.49771690943 | 1378.37952523777 | 1033.31008311858 |
1699 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2006 | 1213.05866122162 | 1388.43583853374 | 1042.66953181578 |
1700 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2007 | 1224.2531421656201 | 1401.64687670933 | 1053.45901346492 |
1701 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2008 | 1237.54187134039 | 1417.29880390258 | 1064.45660311882 |
1702 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2009 | 1249.19974705709 | 1430.26266534419 | 1074.50221344435 |
1703 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2010 | 1265.84972755792 | 1449.7555778522 | 1089.41987312751 |
1704 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2011 | 1278.9013937621 | 1463.85987197989 | 1101.2466552799299 |
1705 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2012 | 1290.51069199887 | 1474.9901881803798 | 1112.27737775982 |
1706 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2013 | 1303.76521235202 | 1490.81115816147 | 1126.20595123401 |
1707 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2014 | 1314.76499251959 | 1503.67890842908 | 1136.58494092537 |
1708 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2015 | 1332.26598539904 | 1521.9084548537 | 1152.30483853751 |
1709 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2016 | 1350.46210054541 | 1543.70465900063 | 1169.00298882892 |
1710 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2017 | 1373.3987044291 | 1571.66353848982 | 1189.89068750234 |
1711 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2018 | 1401.5385981330799 | 1603.87351882931 | 1214.58882665719 |
1712 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2019 | 1427.40083405127 | 1634.70136174933 | 1234.91938081233 |
1713 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 543 | Alzheimer's disease and other dementias | 3 | Rate | 2020 | 1450.17000177959 | 1660.49426412407 | 1253.48788059596 |
1714 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2005 | 408.42168260572 | 551.48832839002 | 275.13518715897 |
1715 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2006 | 405.71844437375 | 544.99943360444 | 274.84698808070004 |
1716 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2007 | 400.38232625076995 | 535.15109618441 | 276.7337459877 |
1717 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2008 | 393.83181243357 | 522.227582514 | 269.16442866376 |
1718 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2009 | 387.38227915505 | 516.63774361981 | 258.10072798049 |
1719 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2010 | 382.73329837431004 | 517.35172899275 | 251.61192842044 |
1720 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2011 | 377.89265160456 | 506.05656038664995 | 250.96088185189 |
1721 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2012 | 371.25263407359 | 497.37910486049 | 250.34439140051 |
1722 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2013 | 364.31289837795 | 484.34956449546 | 248.34939901761 |
1723 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2014 | 358.48424187936 | 472.81702806788996 | 239.74155404290002 |
1724 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2015 | 355.56452480274 | 473.02928597076 | 236.03225164825002 |
1725 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2016 | 354.67173884333 | 462.95480223174 | 238.5431211452 |
1726 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2017 | 354.28138063524 | 464.9216803432 | 240.17312491181002 |
1727 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2018 | 354.4196282489 | 466.68229829945 | 236.38097429146 |
1728 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2019 | 354.97872427122996 | 470.8471184919 | 234.29337675744 |
1729 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 545 | Idiopathic epilepsy | 3 | Rate | 2020 | 357.63702951885 | 484.70095714375 | 235.92520978796 |
1730 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2005 | 15.31738422171 | 18.511057248329998 | 12.42080955069 |
1731 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2006 | 14.978120392849998 | 17.859440036469998 | 12.325181912609999 |
1732 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2007 | 14.61114969276 | 16.99434287865 | 12.18442204103 |
1733 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2008 | 14.2611471778 | 16.455228247289998 | 12.05381612706 |
1734 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2009 | 13.9880067576 | 16.080825019189998 | 11.931811171 |
1735 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2010 | 13.86145753989 | 15.94593101125 | 11.85194252622 |
1736 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2011 | 13.84621565043 | 15.909284507110002 | 11.85250725521 |
1737 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2012 | 13.858474228590001 | 15.90981250122 | 11.879970222839999 |
1738 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2013 | 13.893705712590002 | 15.941120436659999 | 11.91700286261 |
1739 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2014 | 13.94675159062 | 16.00778053878 | 11.9639356043 |
1740 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2015 | 14.00876183337 | 16.09393576668 | 12.011832507140001 |
1741 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2016 | 14.193058082590001 | 16.25293479922 | 12.15699080916 |
1742 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2017 | 14.63362607691 | 16.877468275629997 | 12.3520812161 |
1743 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2018 | 15.353450250589999 | 18.04555292907 | 12.634311210229999 |
1744 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2019 | 16.36936953272 | 19.57570802003 | 13.16679958683 |
1745 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 644 | Orofacial clefts | 3 | Rate | 2020 | 19.6216372455 | 24.968820566490002 | 14.89538556034 |
1746 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2005 | 13193.912417747062 | 15240.126398559969 | 11445.562703992431 |
1747 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2006 | 12976.86960822759 | 14980.2750023916 | 11241.44323008402 |
1748 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2007 | 12472.1622835353 | 14410.02643161935 | 10812.05147463323 |
1749 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2008 | 11880.48696361168 | 13711.51964076034 | 10312.28523989067 |
1750 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2009 | 11397.83045875948 | 13125.150626350249 | 9899.422756284699 |
1751 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2010 | 11214.934025656179 | 12891.0894842981 | 9751.43767257451 |
1752 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2011 | 11244.36060137652 | 12924.425409837078 | 9777.93444088762 |
1753 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2012 | 11275.32765957176 | 12935.1189910415 | 9796.26798217871 |
1754 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2013 | 11308.8676853902 | 12968.131523357179 | 9835.90028842385 |
1755 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2014 | 11349.68736530223 | 13014.53057222656 | 9881.07627290751 |
1756 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2015 | 11399.56292446727 | 13083.61493663538 | 9934.36313275169 |
1757 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2016 | 11640.366085794041 | 13352.16207496187 | 10149.037620101479 |
1758 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2017 | 12098.78673198334 | 13874.87049084942 | 10561.7094572477 |
1759 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2018 | 12562.51316267743 | 14436.059490614562 | 10980.93316189151 |
1760 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2019 | 12816.31070995414 | 14760.37916667615 | 11214.94378516613 |
1761 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 297 | Tuberculosis | 3 | Rate | 2020 | 12838.13282917752 | 14753.143573038571 | 11234.42985690485 |
1762 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2005 | 393.58439526552996 | 580.5922552259 | 217.22752694598 |
1763 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2006 | 399.33626601829 | 590.30614025076 | 220.35178391213 |
1764 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2007 | 404.77526623202004 | 598.41843838743 | 222.55885327223 |
1765 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2008 | 410.19207737915997 | 606.44649840211 | 223.90404779180002 |
1766 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2009 | 416.24952243849 | 615.12707906259 | 225.48071293081 |
1767 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2010 | 422.83611670134 | 623.90293907308 | 229.40899379788002 |
1768 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2011 | 430.21491820301003 | 634.06114339558 | 234.50942115469002 |
1769 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2012 | 437.57499366385 | 642.95765829904 | 239.52378749286999 |
1770 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2013 | 445.26260269052 | 652.65014628747 | 245.02180581706 |
1771 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2014 | 453.52975118934 | 665.06899732233 | 248.98744636083998 |
1772 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2015 | 462.18291046296997 | 673.54880354635 | 252.05161175215 |
1773 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2016 | 471.78799327800004 | 689.7186708484 | 255.87528152171 |
1774 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2017 | 481.60596197588 | 703.46927264255 | 264.59022214928 |
1775 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2018 | 491.30899323959994 | 715.9524720117801 | 267.99676776361 |
1776 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2019 | 500.896494304 | 733.01285401439 | 274.96323903477 |
1777 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 298 | HIV/AIDS | 3 | Rate | 2020 | 509.89705068916004 | 749.5543696957001 | 281.67951999408 |
1778 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2005 | 0.0 | 0.0 | 0.0 |
1779 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2006 | 0.0 | 0.0 | 0.0 |
1780 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2007 | 0.0 | 0.0 | 0.0 |
1781 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2008 | 0.0 | 0.0 | 0.0 |
1782 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2009 | 0.0 | 0.0 | 0.0 |
1783 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2010 | 0.0 | 0.0 | 0.0 |
1784 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2011 | 0.0 | 0.0 | 0.0 |
1785 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2012 | 0.0 | 0.0 | 0.0 |
1786 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2013 | 0.0 | 0.0 | 0.0 |
1787 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2014 | 0.0 | 0.0 | 0.0 |
1788 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2015 | 0.0 | 0.0 | 0.0 |
1789 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2016 | 0.0 | 0.0 | 0.0 |
1790 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2017 | 0.0 | 0.0 | 0.0 |
1791 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2018 | 0.0 | 0.0 | 0.0 |
1792 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2019 | 0.0 | 0.0 | 0.0 |
1793 | 5 | Prevalence | 102 | United States of America | 3 | Both | 22 | All ages | 345 | Malaria | 3 | Rate | 2020 | 0.0 | 0.0 | 0.0 |